# Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting

Daniel Barnett, Kirsten Bohmbach, Valentin Grelot, Alexandre Charlet, Glenn Dallérac, Yeon Ha Ju, Jun Nagai, Anna Orr

<figure><img src="image_1.png" /></figure>

## To cite this version:

Daniel Barnett, Kirsten Bohmbach, Valentin Grelot, Alexandre Charlet, Glenn Dallérac, et al.. Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting. Journal of Neuroscience, 2023, 43 (45), pp.7463-7471. 10.1523/JNEUROSCI.1376-23.2023. hal-04281520

HAL Id: hal-04281520

https://hal.science/hal-04281520

Submitted on 23 May 2024

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

<figure><img src="image_2.png" /></figure>
# Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting

Daniel Barnett, Kirsten Bohmbach, Valentin Grelot, Alexandre Charlet, Glenn Dallérac, Yeon Ha Ju, Jun Nagai, Anna Orr

<figure><img src="image_1.png" /></figure>

## To cite this version:

Daniel Barnett, Kirsten Bohmbach, Valentin Grelot, Alexandre Charlet, Glenn Dallérac, et al.. Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting. Journal of Neuroscience, 2023, 43 (45), pp.7463-7471. 10.1523/JNEUROSCI.1376-23.2023. hal-04281520

HAL Id: hal-04281520

https://hal.science/hal-04281520v1

Submitted on 23 May 2024

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

<figure><img src="image_2.png" /></figure>
Symposium

# Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting

Daniel Barnett,<fnref n="1" />,²,³ Kirsten Bohmbach,⁴ Valentin Grelot,⁵ Alexandre Charlet,⁵ Glenn Dallérac,⁶

Yeon Ha Ju,⁷ Jun Nagai,⁸ and Anna G. Orr<fnref n="1" />,²,³

Astrocytes are emerging as key regulators of cognitive function and behavior. This review highlights some of the latest advances in the understanding of astrocyte roles in different behavioral domains across lifespan and in disease. We address specific molecular and circuit mechanisms by which astrocytes modulate behavior, discuss their functional diversity and versatility, and highlight emerging astrocyte-targeted treatment strategies that might alleviate behavioral and cognitive dysfunction in pathologic conditions. Converging evidence across different model systems and manipulations is revealing that astrocytes regulate behavioral processes in a precise and context-dependent manner. Improved understanding of these astrocytic functions may generate new therapeutic strategies for various conditions with cognitive and behavioral impairments.

## Introduction

Astrocytes regulate diverse brain functions, including information processing and storage (Santello et al., 2019; Kofuji and Araque, 2021). The exact roles of astrocytes in higher cognitive function and behavior are a growing area of neuroscience spurred by new and improved experimental tools and better understanding of astrocyte biology, astrocytic-neuronal interactions, and neural circuit activities underlying cognition and behavior. Accumulating evidence suggests that astrocytes play key roles in cognitive and behavioral processes (Han et al., 2012; H. S. Lee et al., 2014; Habbas et al., 2015; Orr et al., 2015; Gao et al., 2016; Papouin et al., 2017; Adamsky et al., 2018; Curreli et al., 2022; Doron et al., 2022) and that these roles are precise and context-dependent, and vulnerable to perturbation in injury and disease (Rusakov et al., 2014; Chung et al., 2015; Verkratsky and Nedergaard, 2018). Alterations in astrocyte function have been implicated in various disorders of cognition

and behavior (Tong et al., 2014; De Strooper and Karran, 2016; Windrem et al., 2017; Brandebura et al., 2023). In this focused review, we highlight recent studies mainly in mice on the effects of astrocytes on visual processing, learning and memory, emotion, attention, and motor activity in health and disease. These studies suggest that diverse astrocytic factors and molecular pathways regulate normal behavior and can contribute to disease-associated behavioral and cognitive deficits. These insights enhance our understanding of astrocyte function and may facilitate therapeutic advancement for neurocognitive disorders.

## Astrocytes regulate cortical maturation and hippocampal activities underlying normal behavior

Astrocytes are crucial for synaptic development and maturation, and changes to astrocytes in critical periods (CPs) of brain development are implicated in neurodevelopmental disorders (Molofsky et al., 2012; Allen and Eroglu, 2017). Astrocytes are considered crucial elements of brain circuitry that enable synapse formation, maturation, activity, and elimination (Clarke and Barres, 2013). Although how exactly they exert such control is a topic of intense research, it is well known that astrocytes participate in critical developmental periods and affect brain disorders involving synaptic alterations. Unraveling how astrocytes control synaptic circuit formation and maturation is crucial not only for the understanding of normal brain development, but also for identifying effective therapeutics for neurodevelopmental disorders, such as autism spectrum disorder, attention-deficit/hyperactivity disorder, and epilepsy.

In the immature brain, both neurons and astrocytes develop in parallel during the early postnatal period characterized by enhanced

Received July 19, 2023; revised Aug. 13, 2023; accepted Aug. 22, 2023.

This work was supported by the following: National Institutes of Health/National Institute on Aging F31 AG084165 to D.B.; German Research Foundation (Deutsche Forschungsgemeinschaft) SFB1089 to K.B.; Center National de la Recherche Scientifique Contract UPR3212, Université de Strasbourg Contract UPR3212, and Agence Nationale de la Recherche, Jeune Chercheuse Jeune Chercheur Grant 19-CE16-0011-0 to A.C.; European Research Council, UNADEV-Aviesan, Fondation pour la Recherche Médicale, and the French Research Ministry to G.D.; Japan Society for the Promotion of Science KAKENHI JP21H00220, JP21H02588, JP23H04179, JST FOREST JPMJFR2249, and AMED JP22dk0207063 to J.N.; and National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS118569, National Institutes of Health/National Institute on Aging R00AG048222, Alzheimer's Association Research Grant, and Leon Levy Foundation Fellowship in Neuroscience to A.G.O.

The authors declare no competing financial interests.

Correspondence should be addressed to Anna G. Orr at ago2002@med.cornell.edu.

https://doi.org/10.1523/JNEUROSCI.1376-23.2023

Copyright © 2023 the authors

<footnote n="1">¹Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, New York 10021, ²Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021, ³Neuroscience Graduate Program, Weill Cornell Medicine, New York, New York 10021, ⁴Institute of Cellular Neurosciences, Medical Faculty, University of Bonn, 53127 Bonn, Germany, ⁵Institute of Cellular and Integrative Neuroscience, Centre National de la Recherche Scientifique and University of Strasbourg, Strasbourg, 67000, France, ⁶Centre National de la Recherche Scientifique and Paris-Saclay University, Paris-Saclay Institute for Neurosciences, Paris, 91400, France, ⁷Department of Psychiatry and Neuroscience, University of Texas–Austin Dell Medical School, Austin, Texas 78712, and ⁸RIKEN Center for Brain Science, Laboratory for Glia-Neuron Circuit Dynamics, Saitama, 351-0198, Japan</footnote>
# Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting

Daniel Barnett,¹,²,³ Kirsten Bohmbach,⁴ Valentin Grelot,⁵ Alexandre Charlet,⁵ Glenn Dallérac,⁶
Yeon Ha Ju,⁷ Jun Nagai,⁸ and Anna G. Orr¹,²,³

¹Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, New York 10021, ²Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021, ³Neuroscience Graduate Program, Weill Cornell Medicine, New York, New York 10021, ⁴Institute of Cellular Neurosciences, Medical Faculty, University of Bonn, 53127 Bonn, Germany, ⁵Institute of Cellular and Integrative Neuroscience, Centre National de la Recherche Scientifique and University of Strasbourg, Strasbourg, 67000, France, ⁶Centre National de la Recherche Scientifique and Paris-Saclay University, Paris-Saclay Institute for Neurosciences, Paris, 91400, France, ⁷Department of Psychiatry and Neuroscience, University of Texas–Austin Dell Medical School, Austin, Texas 78712, and ⁸RIKEN Center for Brain Science, Laboratory for Glia-Neuron Circuit Dynamics, Saitama, 351-0198, Japan

Astrocytes are emerging as key regulators of cognitive function and behavior. This review highlights some of the latest advan-
ces in the understanding of astrocyte roles in different behavioral domains across lifespan and in disease. We address specific
molecular and circuit mechanisms by which astrocytes modulate behavior, discuss their functional diversity and versatility,
and highlight emerging astrocyte-targeted treatment strategies that might alleviate behavioral and cognitive dysfunction in
pathologic conditions. Converging evidence across different model systems and manipulations is revealing that astrocytes reg-
ulate behavioral processes in a precise and context-dependent manner. Improved understanding of these astrocytic functions
may generate new therapeutic strategies for various conditions with cognitive and behavioral impairments.

Introduction

Astrocytes regulate diverse brain functions, including informa-
tion processing and storage (Santello et al., 2019; Kofuji and
Araque, 2021). The exact roles of astrocytes in higher cogni-
tive function and behavior are a growing area of neuro-
science spurred by new and improved experimental tools and
better understanding of astrocyte biology, astrocytic–neuronal
interactions, and neural circuit activities underlying cognition
and behavior. Accumulating evidence suggests that astrocytes
play key roles in cognitive and behavioral processes (Han et al.,
2012; H. S. Lee et al., 2014; Habbas et al., 2015; Orr et al., 2015;
Gao et al., 2016; Papouin et al., 2017; Adamsky et al., 2018;
Curreli et al., 2022; Doron et al., 2022) and that these roles are
precise and context-dependent, and vulnerable to perturbation
in injury and disease (Rusakov et al., 2014; Chung et al., 2015;
Verkratsky and Nedergaard, 2018). Alterations in astrocyte
function have been implicated in various disorders of cognition

and behavior (Tong et al., 2014; De Strooper and Karran, 2016; Windrem et al., 2017; Brandebura et al., 2023). In this focused review, we highlight recent studies mainly in mice on the effects of astrocytes on visual processing, learning and memory, emotion, attention, and motor activity in health and disease. These studies suggest that diverse astrocytic factors and molecular pathways regulate normal behavior and can contribute to disease-associated behavioral and cognitive deficits. These insights enhance our understanding of astrocyte function and may facilitate therapeutic advancement for neurocognitive disorders.

Astrocytes regulate cortical maturation and hippocampal
activities underlying normal behavior

Astrocytes are crucial for synaptic development and maturation, and changes to astrocytes in critical periods (CPs) of brain development are implicated in neurodevelopmental disorders (Molofsky et al., 2012; Allen and Eroglu, 2017). Astrocytes are considered crucial elements of brain circuitry that enable synapse formation, maturation, activity, and elimination (Clarke and Barres, 2013). Although how exactly they exert such control is a topic of intense research, it is well known that astrocytes participate in critical developmental periods and affect brain disorders involving synaptic alterations. Unraveling how astrocytes control synaptic circuit formation and maturation is crucial not only for the understanding of normal brain development, but also for identifying effective therapeutics for neurodevelopmental disorders, such as autism spectrum disorder, attention-deficit/hyperactivity disorder, and epilepsy.

In the immature brain, both neurons and astrocytes develop in
parallel during the early postnatal period characterized by enhanced

Received July 19, 2023; revised Aug. 13, 2023; accepted Aug. 22, 2023.

This work was supported by the following: National Institutes of Health/National Institute on Aging F31 AG084165 to D.B.; German Research Foundation (Deutsche Forschungsgemeinschaft) SFB1089 to K.B.; Center National de la Recherche Scientifique Contract UPR3212, Université de Strasbourg Contract UPR3212, and Agence Nationale de la Recherche, Jeune Chercheuse Jeune Chercheur Grant 19-CE16-0011-0 to A.C.; European Research Council, UNADEV-Aviesan, Fondation pour la Recherche Médicale, and the French Research Ministry to G.D.; Japan Society for the Promotion of Science KAKENHI JP21H00220, JP21H02588, JP23H04179, JST FOREST JPMJFR2249, and AMED JP22dk0207063 to J.N.; and National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS118569, National Institutes of Health/National Institute on Aging R00AG048222, Alzheimer's Association Research Grant, and Leon Levy Foundation Fellowship in Neuroscience to A.G.O.

The authors declare no competing financial interests.

Correspondence should be addressed to Anna G. Orr at ago2002@med.cornell.edu.

https://doi.org/10.1523/JNEUROSCI.1376-23.2023
plasticity-related processes. In the first weeks of life, there is a period of massive synaptogenesis followed by selective pruning of synapses and sculpting of synaptic connections. These processes result in sensitive periods, known as CPs, involving enhanced neuroplasticity during which synaptic networks are shaped by experience in postnatal development. Synapse elimination may occur through engulfing mechanisms involving astrocytic MEGF10 and MERTK-dependent phagocytic pathways, which are strongly influenced by local neuronal activities (Chung et al., 2013). Conversely, astrocytes may also control CP by releasing various synaptogenic factors. For instance, at thalamocortical synapses, astrocytes can secrete the glycoprotein hevin, which facilitates the development of glutamatergic synapses between the thalamus and neocortex. The effects of hevin involve the bridging of presynaptic factor neurexin-1α with the postsynaptic factor neuroligin-1 (Singh et al., 2016).

The exact time windows for CP and neural network formation vary between cerebral areas and their functions (Hensch, 2005). Importantly, closure of the CP and stabilization of neural circuits rely on activity-dependent maturation of local inhibitory networks, in particular parvalbumin-expressing GABAergic interneurons. The visual cortex is well known to undergo experience-dependent developmental shaping of synaptic circuits during its CP with enhanced plasticity that follows eye opening. Primary visual areas in the cortex are typically activated more by contralateral compared with ipsilateral eye stimulation, which is termed ocular dominance. The start and end of visual cortex CP is classically defined according to the development of ocular dominance.

Ocular dominance can be manipulated experimentally by occlusion of the contralateral eye for several days, which abolishes dominance or switches it to the ipsilateral eye. Pioneering studies have revealed a key role of astrocytes in the timing of the visual CP by showing that implantation of immature astrocytes into the visual cortex is sufficient to reopen a period of enhanced plasticity (Muller and Best, 1989). More recently, Ribot et al. (2021) unveiled the mechanisms by which astrocytes modulate the wiring of visual circuits. Astrocytes in the visual cortex were shown to regulate the extracellular matrix that promotes maturation of interneurons, and this process involves unconventional connexin signaling in astrocytes. In particular, the timing of CP closure was controlled by marked developmental upregulation of astrocytic connexin-30, which inhibited the expression of matrix-degrading enzyme matrix metallopeptidase 9 through the RhoA-GTPase pathway. These findings suggest that astrocytes control experience-dependent wiring of neuronal circuits in neurodevelopment that enable visual processing. Interestingly, in parallel work using *Drosophila melanogaster*, studies have also uncovered astrocyte roles in the closure of a newly discovered CP for motor behavior (Ackerman et al., 2021). Here, astrocytes appear to promote the end of CP by disrupting the balance between excitation and inhibition through astrocyte-derived neuroligins and their neuronal target neurexin-1. This work and other studies suggest that astrocytes in insects and mammals regulate early neuroplasticity and that astrocytes have determinant roles in early sculpting of synaptic connections and maturation of neural circuits involved in perception and behavior.

Astrocytes also modulate synaptic function and neural circuits in the hippocampus of young and adult animals. For instance, astrocytes influence dendritic computations essential for spatial learning and memory and other processes. The understanding of microcircuit computations underlying spatial learning has grown

steadily (Geiller et al., 2023) since the discovery of place cells in the hippocampus by O'Keefe and Dostrovsky (1971). While the initial focus was centered on somatic neuronal activities, recent studies have identified a crucial role for active dendritic computations in shaping place field firing patterns and spatial learning (Sheffield and Dombeck, 2019). Similarly, the roles of astrocytes in spatial learning has gained increased attention (Akther and Hirase, 2022; Bohmbach et al., 2023). In particular, astrocytic $Ca^{2+}$ signaling in the hippocampus has been shown to modulate synaptic transmission and plasticity underlying spatial learning (Perea and Araque, 2005, 2007; Shigetomi et al., 2008; Di Castro et al., 2011; Panatier et al., 2011), and can predict the location of an expected reward (Doron et al., 2022). However, exactly when astrocytic $Ca^{2+}$ signaling pathways are recruited and whether they modulate dendritic computation remained unknown until recently.

In the stratum radiatum of the CA1 region in the hippocampus, active dendritic integration can amplify simultaneous clustered inputs through the generation of dendritic spikes (Losonczy and Magee, 2006; Stuart and Spruston, 2015). This nonlinear dendritic computation has been shown to modulate long-term plasticity (Remy and Spruston, 2007), complex burst firing (Grienberger et al., 2014), and the formation of place cells (Sheffield and Dombeck, 2015; Sheffield et al., 2017). As NMDAR signaling is crucial for dendritic spikes (Losonczy and Magee, 2006; Grienberger et al., 2014; Harnett et al., 2015; Bohmbach et al., 2022) and astrocytes are known to modulate NMDARs through the supply of the co-agonist D-serine (Henneberger et al., 2010; Papouin et al., 2017; Robin et al., 2018), it was hypothesized that astrocytes modulate dendritic computations. Through a series of *ex vivo* electrophysiological experiments, Bohmbach et al. (2022) revealed that the co-agonist binding site of NMDARs allows the modulation of dendritic spikes and that this effect was mediated by an increase in the NMDAR co-agonist D-serine. However, important questions remain. How do neurons engage astrocytes to enhance D-serine release and what is the exact mechanism regulating astrocytic D-serine release?

Neuronal firing can increase endocannabinoid levels, which are lipophilic substances with short-range neuromodulatory actions (Di Marzo et al., 1998; Wilson and Nicoll, 2002; Chevaleyre and Castillo, 2003; Fortin et al., 2004; Dubruc et al., 2013; Albarran et al., 2023). Astrocytes express endocannabinoid receptors, including Type 1 cannabinoid receptors (CB1R), which regulate astrocytic $Ca^{2+}$ levels (Navarrete and Araque, 2008), synaptic plasticity and memory (Han et al., 2012; Min and Nevian, 2012), and metabolic processes (Jimenez-Blasco et al., 2020; Covelo et al., 2021). In addition, CB1R is involved in $Ca^{2+}$-dependent release of gliotransmitters, including D-serine (Gomez-Gonzalo et al., 2015; Robin et al., 2018; Bohmbach et al., 2022). Bohmbach et al. (2022) demonstrated that astrocytes respond to neural activity via the activation of endocannabinoid receptors, which are recruited for D-serine release. In turn, astrocyte-derived D-serine modulated neurotransmission by lowering the threshold and increasing the amplitude of dendritic spikes. Overall, these results suggest that hippocampal astrocytes control dendritic computations through endocannabinoid receptor activation and $Ca^{2+}$-dependent release of D-serine that enhances dendritic NMDAR activation.

Bohmbach et al. (2022) also investigated when and how this astrocytic modulation is recruited. Importantly, the recruitment of astrocytic $Ca^{2+}$ and subsequent modulation of dendritic
plasticity-related processes. In the first weeks of life, there is a period of massive synaptogenesis followed by selective pruning of synapses and sculpting of synaptic connections. These processes result in sensitive periods, known as CPs, involving enhanced neuroplasticity during which synaptic networks are shaped by experience in postnatal development. Synapse elimination may occur through engulfing mechanisms involving astrocytic MEGF10 and MERTK-dependent phagocytic pathways, which are strongly influenced by local neuronal activities (Chung et al., 2013). Conversely, astrocytes may also control CP by releasing various synaptogenic factors. For instance, at thalamocortical synapses, astrocytes can secrete the glycoprotein hevin, which facilitates the development of glutamatergic synapses between the thalamus and neocortex. The effects of hevin involve the bridging of presynaptic factor neurexin-1α with the postsynaptic factor neuroligin-1 (Singh et al., 2016).

The exact time windows for CP and neural network formation vary between cerebral areas and their functions (Hensch, 2005). Importantly, closure of the CP and stabilization of neural circuits rely on activity-dependent maturation of local inhibitory networks, in particular parvalbumin-expressing GABAergic interneurons. The visual cortex is well known to undergo experience-dependent developmental shaping of synaptic circuits during its CP with enhanced plasticity that follows eye opening. Primary visual areas in the cortex are typically activated more by contralateral compared with ipsilateral eye stimulation, which is termed ocular dominance. The start and end of visual cortex CP is classically defined according to the development of ocular dominance.

Ocular dominance can be manipulated experimentally by occlusion of the contralateral eye for several days, which abolishes dominance or switches it to the ipsilateral eye. Pioneering studies have revealed a key role of astrocytes in the timing of the visual CP by showing that implantation of immature astrocytes into the visual cortex is sufficient to reopen a period of enhanced plasticity (Muller and Best, 1989). More recently, Ribot et al. (2021) unveiled the mechanisms by which astrocytes modulate the wiring of visual circuits. Astrocytes in the visual cortex were shown to regulate the extracellular matrix that promotes maturation of interneurons, and this process involves unconventional connexin signaling in astrocytes. In particular, the timing of CP closure was controlled by marked developmental upregulation of astrocytic connexin-30, which inhibited the expression of matrix-degrading enzyme matrix metallopeptidase 9 through the RhoA-GTPase pathway. These findings suggest that astrocytes control experience-dependent wiring of neuronal circuits in neurodevelopment that enable visual processing. Interestingly, in parallel work using *Drosophila melanogaster*, studies have also uncovered astrocyte roles in the closure of a newly discovered CP for motor behavior (Ackerman et al., 2021). Here, astrocytes appear to promote the end of CP by disrupting the balance between excitation and inhibition through astrocyte-derived neuroligins and their neuronal target neurexin-1. This work and other studies suggest that astrocytes in insects and mammals regulate early neuroplasticity and that astrocytes have determinant roles in early sculpting of synaptic connections and maturation of neural circuits involved in perception and behavior.

Astrocytes also modulate synaptic function and neural circuits in the hippocampus of young and adult animals. For instance, astrocytes influence dendritic computations essential for spatial learning and memory and other processes. The understanding of microcircuit computations underlying spatial learning has grown

steadily (Geiller et al., 2023) since the discovery of place cells in the hippocampus by O'Keefe and Dostrovsky (1971). While the initial focus was centered on somatic neuronal activities, recent studies have identified a crucial role for active dendritic computations in shaping place field firing patterns and spatial learning (Sheffield and Dombeck, 2019). Similarly, the roles of astrocytes in spatial learning has gained increased attention (Akther and Hirase, 2022; Bohmbach et al., 2023). In particular, astrocytic $Ca^{2+}$ signaling in the hippocampus has been shown to modulate synaptic transmission and plasticity underlying spatial learning (Perea and Araque, 2005, 2007; Shigetomi et al., 2008; Di Castro et al., 2011; Panatier et al., 2011), and can predict the location of an expected reward (Doron et al., 2022). However, exactly when astrocytic $Ca^{2+}$ signaling pathways are recruited and whether they modulate dendritic computation remained unknown until recently.

In the stratum radiatum of the CA1 region in the hippocampus, active dendritic integration can amplify simultaneous clustered inputs through the generation of dendritic spikes (Losonczy and Magee, 2006; Stuart and Spruston, 2015). This nonlinear dendritic computation has been shown to modulate long-term plasticity (Remy and Spruston, 2007), complex burst firing (Grienberger et al., 2014), and the formation of place cells (Sheffield and Dombeck, 2015; Sheffield et al., 2017). As NMDAR signaling is crucial for dendritic spikes (Losonczy and Magee, 2006; Grienberger et al., 2014; Harnett et al., 2015; Bohmbach et al., 2022) and astrocytes are known to modulate NMDARs through the supply of the co-agonist D-serine (Henneberger et al., 2010; Papouin et al., 2017; Robin et al., 2018), it was hypothesized that astrocytes modulate dendritic computations. Through a series of *ex vivo* electrophysiological experiments, Bohmbach et al. (2022) revealed that the co-agonist binding site of NMDARs allows the modulation of dendritic spikes and that this effect was mediated by an increase in the NMDAR co-agonist D-serine. However, important questions remain. How do neurons engage astrocytes to enhance D-serine release and what is the exact mechanism regulating astrocytic D-serine release?

Neuronal firing can increase endocannabinoid levels, which are lipophilic substances with short-range neuromodulatory actions (Di Marzo et al., 1998; Wilson and Nicoll, 2002; Chevaleyre and Castillo, 2003; Fortin et al., 2004; Dubruc et al., 2013; Albarran et al., 2023). Astrocytes express endocannabinoid receptors, including Type 1 cannabinoid receptors (CB1R), which regulate astrocytic $Ca^{2+}$ levels (Navarrete and Araque, 2008), synaptic plasticity and memory (Han et al., 2012; Min and Nevian, 2012), and metabolic processes (Jimenez-Blasco et al., 2020; Covelo et al., 2021). In addition, CB1R is involved in $Ca^{2+}$-dependent release of gliotransmitters, including D-serine (Gomez-Gonzalo et al., 2015; Robin et al., 2018; Bohmbach et al., 2022). Bohmbach et al. (2022) demonstrated that astrocytes respond to neural activity via the activation of endocannabinoid receptors, which are recruited for D-serine release. In turn, astrocyte-derived D-serine modulated neurotransmission by lowering the threshold and increasing the amplitude of dendritic spikes. Overall, these results suggest that hippocampal astrocytes control dendritic computations through endocannabinoid receptor activation and $Ca^{2+}$-dependent release of D-serine that enhances dendritic NMDAR activation.

Bohmbach et al. (2022) also investigated when and how this astrocytic modulation is recruited. Importantly, the recruitment of astrocytic $Ca^{2+}$ and subsequent modulation of dendritic
integration by D-serine exhibited a distinct activity-dependent pattern. While low (4 Hz) and high (40 Hz) frequency neuronal firing did not recruit astrocytic modulation, firing rates in the theta band (~10 Hz) recruited reciprocal signaling between astrocytes and neurons. This activity-based engagement of astrocytes is likely mediated by dendrites themselves, as blockade of hyperpolarization-activated cyclic nucleotide-gated channels impaired feedback signaling. Moreover, Bohmbach et al. (2022) showed that this positive feedback exerted by astrocytes is required for spatial learning and memory. Decreasing intracellular $Ca^{2+}$ levels through the expression of hPMCA2, a $Ca^{2+}$ ATPase (also known as CalEx), or ablating the cannabinoid receptor CB1R specifically in astrocytes disrupted this astrocytic–neuronal cross-talk and impaired memory.

These findings and related work illustrate that astrocytes modulate spatial learning-related processes in the hippocampus and are engaged by specific types of neuronal activity patterns to modulate dendritic input computations. Further studies are needed to determine whether additional neuronal factors act on astrocytes to control these mechanisms and whether specific patterns of neural activities in other brain regions similarly recruit astrocytic feedforward mechanisms.

## Astrocytes modulate neural circuits in the amygdala and striatum to affect various behavioral domains

Astrocytes in different brain regions have distinct transcriptomic, structural, and functional properties (Chai et al., 2017; Morel et al., 2017; Endo et al., 2022), and these regional differences are also evident in aging and disease (Clarke et al., 2018; Hasel et al., 2021; Burda et al., 2022; Endo et al., 2022). Throughout the brain, astrocytes are responsive to various factors, including neurotransmitters and neuropeptides, that likely promote distinct astrocytic functions among different brain regions and circuits. In particular, recent studies have explored the roles of astrocytes in the effects of oxytocin (OT), a neuropeptide known for its regulation of various behavioral functions ranging from social interactions to pain and anxiety (Eliava et al., 2016; Jurek and Neumann, 2018; Hasan et al., 2019; Tang et al., 2020; Wahis et al., 2021; Iwasaki et al., 2023). Mainly synthesized in the hypothalamus, OT reaches distant brain nuclei through long-range axonal projections of OT-synthetizing neurons (Zhang et al., 2021). Once locally released, OT binds to its transmembrane receptor (OTR). While in the past, the effects of OT were mostly attributed to neuronal OTR and its direct effects on neuronal activities, new findings have uncovered a crucial role for astrocytes in OT-induced neuromodulation in the amygdala (Wahis et al., 2021; Baudon et al., 2022).

The central amygdala (CeA) is a key nucleus in the brain involved in the regulation of emotion. Wahis et al. (2021) found that a specific subpopulation of CeA astrocytes expresses OTR. Strikingly, these astrocytes appeared to be larger, more complex, and more likely to be connected to neighboring astrocytes compared with astrocytes lacking OTR expression. In *ex vivo* slice preparations, evoked OT release using optogenetics or direct OTR activation using TGOT, a selective OTR agonist, led to the appearance or significant increases in astrocytic $Ca^{2+}$ transients. Targeted genetic deletion of the OTR-encoding gene specifically in CeA astrocytes revealed that CeA astrocytes express functional OTR. The authors evaluated the functional impact of OTR-induced astrocytic $Ca^{2+}$ transients on the CeA neuronal network. To this end, patch-clamp recordings of electrical activities and currents in CeA neurons revealed strong modulation of CeA

neuronal activity by astrocytic OTRs. These effects were mediated by neuronal NMDARs at least in part through astrocytic release of D-serine. Given the crucial roles of CeA in emotional behavior, Wahis et al. (2021) also explored the behavioral effects of astrocytic OTR using a neuropathic pain model and measuring nociceptive thresholds, and assessing anxiety-like behavior and place preferences. Although there was not a strong involvement of OTR in nociception, activation of OTR reduced anxiety-like behavior and increased place preference; and these effects were dependent on CeA astrocytes.

These findings suggest that astrocytic OTR activation in the CeA induces astrocytic $Ca^{2+}$ transients and transmitter release that modulate neuronal activity and emotion-related behaviors (Wahis et al., 2021). However, many important questions remain. Do astrocyte-mediated effects by OT differ according to brain region and pathophysiological state? Which intracellular pathways does astrocytic OTR recruit, and are there long-term effects of astrocytic OTR activation on astrocyte–neuronal interactions and behavioral functions (Baudon et al., 2022)? Further research is necessary to unravel the exact mechanisms and roles of astrocytes in emotion-linked circuits and behaviors and their changes in pathologic conditions that involve emotional dysregulation.

Astrocytes also regulate neural circuits involved in movement and attentional behaviors. Recent studies have explored the importance of astrocytes in cognitive processes related to how organisms exploit external stimuli for action selection. This process is heavily influenced by the striatum, a major input region of the basal ganglia, an area of the brain that coordinates voluntary movements directed by the cerebral cortex and regulates motor functions, innate behaviors, and cognitive processes, such as reinforcement learning (Graybiel, 2008; Markowitz et al., 2018). Intricate intercellular signaling plays pivotal roles in striatal microcircuits, and impairments in these mechanisms are implicated in neurodegenerative disorders, such as Parkinson's disease and Huntington's disease, and in drug addiction (Burguiere et al., 2015; Graybiel and Grafton, 2015; Khakh, 2019).

Astrocytes tile the striatum, where ~95% of neurons are GABAergic medium spiny neurons (MSNs). Striatal astrocytes respond to MSN activities through $G_i$-coupled GABA$_B$ receptors, leading to increases in intracellular $Ca^{2+}$ levels (Nagai et al., 2019). Accumulating evidence suggests that striatal astrocytes regulate behavior. In particular, recent studies have manipulated $Ca^{2+}$ signaling and metabotropic receptor activation in striatal astrocytes using membrane-targeted expression of $Ca^{2+}$ ATPase (CalEx) (Yu et al., 2018, 2021) or chemogenetic stimulation of $G_i$-coupled DREADDs. Silencing astrocytic $Ca^{2+}$ signaling with CalEx caused an increase in astrocytic expression of GABA transporter GAT3, which induced repetitive self-grooming behavior in mice that is reminiscent of obsessive-compulsive disorder (Yu et al., 2018). Furthermore, Nagai et al. (2019) revealed that chemogenetic activation of astrocytic $G_i$-coupled receptors using hM4Di enhanced cortico-striatal excitatory synaptic transmission through aberrant induction of a synaptogenic molecule, thrombospondin-1, which induced behavioral hyperactivity and disrupted attention. These findings suggest that re-activation of astrocytic factors required in neurodevelopment can cause behavioral impairments in adulthood.

Striatal astrocytes are also instrumental in modulating reward-seeking behavior and behavioral flexibility. In particular, chemogenetic activation of $G_q$-coupled receptors in astrocytes located in the dorsomedial striatum modulates synaptic transmission in direct and indirect pathway MSNs in distinct ways,
integration by D-serine exhibited a distinct activity-dependent pattern. While low (4 Hz) and high (40 Hz) frequency neuronal firing did not recruit astrocytic modulation, firing rates in the theta band (~10 Hz) recruited reciprocal signaling between astrocytes and neurons. This activity-based engagement of astrocytes is likely mediated by dendrites themselves, as blockade of hyperpolarization-activated cyclic nucleotide-gated channels impaired feedback signaling. Moreover, Bohmbach et al. (2022) showed that this positive feedback exerted by astrocytes is required for spatial learning and memory. Decreasing intracellular $Ca^{2+}$ levels through the expression of hPMCA2, a $Ca^{2+}$ ATPase (also known as CalEx), or ablating the cannabinoid receptor CB1R specifically in astrocytes disrupted this astrocytic-neuronal cross-talk and impaired memory.

These findings and related work illustrate that astrocytes modulate spatial learning-related processes in the hippocampus and are engaged by specific types of neuronal activity patterns to modulate dendritic input computations. Further studies are needed to determine whether additional neuronal factors act on astrocytes to control these mechanisms and whether specific patterns of neural activities in other brain regions similarly recruit astrocytic feedforward mechanisms.

## Astrocytes modulate neural circuits in the amygdala and striatum to affect various behavioral domains

Astrocytes in different brain regions have distinct transcriptomic, structural, and functional properties (Chai et al., 2017; Morel et al., 2017; Endo et al., 2022), and these regional differences are also evident in aging and disease (Clarke et al., 2018; Hasel et al., 2021; Burda et al., 2022; Endo et al., 2022). Throughout the brain, astrocytes are responsive to various factors, including neurotransmitters and neuropeptides, that likely promote distinct astrocytic functions among different brain regions and circuits. In particular, recent studies have explored the roles of astrocytes in the effects of oxytocin (OT), a neuropeptide known for its regulation of various behavioral functions ranging from social interactions to pain and anxiety (Eliava et al., 2016; Jurek and Neumann, 2018; Hasan et al., 2019; Tang et al., 2020; Wahis et al., 2021; Iwasaki et al., 2023). Mainly synthesized in the hypothalamus, OT reaches distant brain nuclei through long-range axonal projections of OT-synthetizing neurons (Zhang et al., 2021). Once locally released, OT binds to its transmembrane receptor (OTR). While in the past, the effects of OT were mostly attributed to neuronal OTR and its direct effects on neuronal activities, new findings have uncovered a crucial role for astrocytes in OT-induced neuromodulation in the amygdala (Wahis et al., 2021; Baudon et al., 2022).

The central amygdala (CeA) is a key nucleus in the brain involved in the regulation of emotion. Wahis et al. (2021) found that a specific subpopulation of CeA astrocytes expresses OTR. Strikingly, these astrocytes appeared to be larger, more complex, and more likely to be connected to neighboring astrocytes compared with astrocytes lacking OTR expression. In *ex vivo* slice preparations, evoked OT release using optogenetics or direct OTR activation using TGOT, a selective OTR agonist, led to the appearance or significant increases in astrocytic $Ca^{2+}$ transients. Targeted genetic deletion of the OTR-encoding gene specifically in CeA astrocytes revealed that CeA astrocytes express functional OTR. The authors evaluated the functional impact of OTR-induced astrocytic $Ca^{2+}$ transients on the CeA neuronal network. To this end, patch-clamp recordings of electrical activities and currents in CeA neurons revealed strong modulation of CeA

neuronal activity by astrocytic OTRs. These effects were mediated by neuronal NMDARs at least in part through astrocytic release of D-serine. Given the crucial roles of CeA in emotional behavior, Wahis et al. (2021) also explored the behavioral effects of astrocytic OTR using a neuropathic pain model and measuring nociceptive thresholds, and assessing anxiety-like behavior and place preferences. Although there was not a strong involvement of OTR in nociception, activation of OTR reduced anxiety-like behavior and increased place preference; and these effects were dependent on CeA astrocytes.

These findings suggest that astrocytic OTR activation in the CeA induces astrocytic $Ca^{2+}$ transients and transmitter release that modulate neuronal activity and emotion-related behaviors (Wahis et al., 2021). However, many important questions remain. Do astrocyte-mediated effects by OT differ according to brain region and pathophysiological state? Which intracellular pathways does astrocytic OTR recruit, and are there long-term effects of astrocytic OTR activation on astrocyte-neuronal interactions and behavioral functions (Baudon et al., 2022)? Further research is necessary to unravel the exact mechanisms and roles of astrocytes in emotion-linked circuits and behaviors and their changes in pathologic conditions that involve emotional dysregulation.

Astrocytes also regulate neural circuits involved in movement and attentional behaviors. Recent studies have explored the importance of astrocytes in cognitive processes related to how organisms exploit external stimuli for action selection. This process is heavily influenced by the striatum, a major input region of the basal ganglia, an area of the brain that coordinates voluntary movements directed by the cerebral cortex and regulates motor functions, innate behaviors, and cognitive processes, such as reinforcement learning (Graybiel, 2008; Markowitz et al., 2018). Intricate intercellular signaling plays pivotal roles in striatal microcircuits, and impairments in these mechanisms are implicated in neurodegenerative disorders, such as Parkinson's disease and Huntington's disease, and in drug addiction (Burguiere et al., 2015; Graybiel and Grafton, 2015; Khakh, 2019).

Astrocytes tile the striatum, where ~95% of neurons are GABAergic medium spiny neurons (MSNs). Striatal astrocytes respond to MSN activities through $G_i$-coupled $GABA_B$ receptors, leading to increases in intracellular $Ca^{2+}$ levels (Nagai et al., 2019). Accumulating evidence suggests that striatal astrocytes regulate behavior. In particular, recent studies have manipulated $Ca^{2+}$ signaling and metabotropic receptor activation in striatal astrocytes using membrane-targeted expression of $Ca^{2+}$ ATPase (CalEx) (Yu et al., 2018, 2021) or chemogenetic stimulation of $G_i$-coupled DREADDs. Silencing astrocytic $Ca^{2+}$ signaling with CalEx caused an increase in astrocytic expression of GABA transporter GAT3, which induced repetitive self-grooming behavior in mice that is reminiscent of obsessive-compulsive disorder (Yu et al., 2018). Furthermore, Nagai et al. (2019) revealed that chemogenetic activation of astrocytic $G_i$-coupled receptors using hM4Di enhanced cortico-striatal excitatory synaptic transmission through aberrant induction of a synaptogenic molecule, thrombospondin-1, which induced behavioral hyperactivity and disrupted attention. These findings suggest that re-activation of astrocytic factors required in neurodevelopment can cause behavioral impairments in adulthood.

Striatal astrocytes are also instrumental in modulating reward-seeking behavior and behavioral flexibility. In particular, chemogenetic activation of $G_q$-coupled receptors in astrocytes located in the dorsomedial striatum modulates synaptic transmission in direct and indirect pathway MSNs in distinct ways,
promoting a shift from habitual behavior to goal-directed behavior (Kang et al., 2020). Astrocytic $G_q$-coupled signaling can also preserve behavioral flexibility and action switching by decreasing the expression of the glutamate transporter GLT-1, which prevents excessive glutamate clearance (Boender et al., 2021). Ventrostriatal astrocytes also respond to increases in extracellular dopamine, which can be induced by blocking dopamine transporters with psychostimulants. The increases in dopamine augment astrocytic $Ca^{2+}$ levels and influence synaptic depression and addiction behavior (Corkrum et al., 2020; J. Wang et al., 2021). Beyond GPCRs, astrocytic GluN2C-containing NMDARs can also mediate $Ca^{2+}$ signaling (Chipman et al., 2021), and this mechanism is suggested to maintain cocaine preference memory (Shelkar et al., 2022). The diverse array of astrocytic mechanisms and effects on striatum-dependent behaviors highlight the engagement of astrocytes in diverse neural processing and the functional variation observed within brain regions (Khakh and Deneen, 2019; Endo et al., 2022) in terms of intercellular signaling (Akther and Hirase, 2022), behavioral modulation (Nagai et al., 2021a, 2021b), and disease type and progression (Escartin et al., 2021; Burda et al., 2022).

Further understanding the specific contributions of striatal astrocytes to behavioral functions may reveal new therapeutic targets for conditions, such as Huntington's disease (H. G. Lee et al., 2022). Striatal astrocytes have highly context-specific molecular responses in disease, as evidenced by differential changes in gene expression patterns across 14 experimental perturbations (Yu et al., 2020). Chemogenetic stimulation of astrocytic $G_i$-coupled signaling in models of Huntington's disease pathology led to improvements in some, but not all, behavioral symptoms through increased expression of thrombospondin-1. Thus, stimulating $G_i$-coupled receptors in astrocytes could promote synapse formation and may offer a potential therapeutic approach for conditions characterized by synaptic loss (Yu et al., 2020). Future studies should address the complex interactions of astrocytes with neurons and other cell types within the striatum and throughout the cortico-basal ganglia circuits to better understand localized and broader effects of astrocytes in this region.

In summary, astrocytes have essential roles in synaptic transmission, plasticity, and behavioral control in the striatum and amygdala, highlighting the potential importance of astrocytes in the broader landscape of neurologic and neuropsychiatric disorders.

## Astrocytes have context-dependent and multifactorial roles in neurocognitive disorders

Astrocytes are increasingly recognized as having phenotypic diversity and functional versatility (Haustein et al., 2014; Khakh and Sofroniew, 2015; Ben Haim and Rowitch, 2017; Chai et al., 2017; John Lin et al., 2017; Morel et al., 2017; Patani et al., 2023; Soto et al., 2023). As mentioned above, astrocytic features and effects can vary across brain regions and neural circuits. Astrocytes are also affected by brain maturation and aging (Sun et al., 2013; Boisvert et al., 2018; Clarke et al., 2018; Lattke et al., 2021; E. Lee et al., 2022), sex (Bracchi-Ricard et al., 2008; Baier et al., 2022; Krawczyk et al., 2022; Meadows et al., 2022), and genetic variations (Messing et al., 2012; Arnaud et al., 2022), and they are sensitive to sensory processing (Schummers et al., 2008), locomotion (Paukert et al., 2014), arousal (Rasmussen et al., 2023; Reitman et al., 2023; F. Wang et al., 2023), metabolic and dietary cues (Camandola, 2018; Jimenez-Blasco et al., 2020; Nampoothiri et al., 2022; Morant-Ferrando et al., 2023), and stressors, such as sleep deprivation

(Bellesi et al., 2017), social isolation (Cheng et al., 2023), and viral infections (Soung and Klein, 2018; Jorgacevski and Potokar, 2023). It is possible that astrocytes play precise and context-dependent roles as a result of their integrated processing of diverse cues inherent to different biological and environmental contexts.

In brain injury and disease, astrocytic responses are emerging as highly context-dependent. These dynamics are becoming particularly evident in neurodegenerative disorders, including Alzheimer's disease (AD) and related dementias. Astrocytes express or respond to most, if not all, dementia-associated factors (Bruijn et al., 1997; Gu et al., 2010; Serio et al., 2013; Sun et al., 2015; di Domenico et al., 2019; Sadick and Liddelow, 2019; Patani et al., 2023) and show extensive changes in gene expression patterns and functional characteristics depending on age (Soreq et al., 2017; Boisvert et al., 2018; Clarke et al., 2018), type of pathology (Delekate et al., 2014; Orr et al., 2015; Jiang et al., 2016; Liddelow et al., 2017; Giovannoni and Quintana, 2020), and exact brain region (Boisvert et al., 2018; Clarke et al., 2018; Itoh et al., 2018). Indeed, astrocytes have highly diversified transcriptional signatures in different pathologic contexts at least in part because of the combinatorial effects of various transcriptional regulators (Burda et al., 2022).

Astrocytic context specificity is further evident in the cell-autonomous effects of dementia-related proteinopathy on astrocytic gene expression and astrocytic regulation of specific neuronal functions. One of the central pathogenic proteins implicated in neurodegenerative disorders is transactivating response region DNA-binding protein 43 (TDP-43), a multifunctional and ubiquitous DNA/RNA-binding factor that localizes primarily in the nucleus and regulates RNA processing and trafficking, among other functions. In disease, TDP-43 accumulates in the cytoplasm and other subcellular compartments, and is a major component of protein inclusions in amyotrophic lateral sclerosis and frontotemporal dementia (Arai et al., 2006; Neumann et al., 2006; T. J. Cohen et al., 2011). Notably, TDP-43 is also implicated in AD and other conditions that cause behavioral impairments (Amador-Ortiz et al., 2007; Uryu et al., 2008; Davidson et al., 2011; Nag et al., 2015). In addition to its effects in neurons, TDP-43 also affects glial cells and likely promotes disease by multiple mechanisms (Uryu et al., 2008; Diaper et al., 2013; Serio et al., 2013; Uchino et al., 2015; Takeuchi et al., 2016; Paolicelli et al., 2017; Weskamp et al., 2020). In support, aberrant astrocytic cleavage or accumulation of TDP-43 has been detected in amyotrophic lateral sclerosis, frontotemporal dementia, and AD (Serio et al., 2013; Takeuchi et al., 2016; Weskamp et al., 2020; Licht-Murava et al., 2023), but exactly how astrocytic TDP-43 dysregulation affects astrocyte function, astrocytic-neuronal interactions, and behavior was not clear.

New findings by Licht-Murava et al. (2023) indicate that aberrant buildup of TDP-43 in astrocytes is sufficient to cause progressive memory loss, but not other types of behavioral impairments, suggesting that hippocampal astrocytes are more vulnerable to TDP-43 pathology compared with astrocytes in other brain regions. Although hippocampal pathology and dysfunction are prevalent in aging and dementia, exact causes are uncertain and treatment options for neurocognitive decline in dementia are limited. In the context of TDP-43 pathology, Licht-Murava et al. (2023) uncovered abnormal increases in antiviral gene activities in hippocampal astrocytes and excessive production of interferon-inducible chemokines. These chemokines are known to activate $G_i$-coupled CXCR3 receptors, which are typically enriched in
promoting a shift from habitual behavior to goal-directed behavior (Kang et al., 2020). Astrocytic $G_q$-coupled signaling can also preserve behavioral flexibility and action switching by decreasing the expression of the glutamate transporter GLT-1, which prevents excessive glutamate clearance (Boender et al., 2021). Ventrostriatal astrocytes also respond to increases in extracellular dopamine, which can be induced by blocking dopamine transporters with psychostimulants. The increases in dopamine augment astrocytic $Ca^{2+}$ levels and influence synaptic depression and addiction behavior (Corkrum et al., 2020; J. Wang et al., 2021). Beyond GPCRs, astrocytic GluN2C-containing NMDARs can also mediate $Ca^{2+}$ signaling (Chipman et al., 2021), and this mechanism is suggested to maintain cocaine preference memory (Shelkar et al., 2022). The diverse array of astrocytic mechanisms and effects on striatum-dependent behaviors highlight the engagement of astrocytes in diverse neural processing and the functional variation observed within brain regions (Khakh and Deneen, 2019; Endo et al., 2022) in terms of intercellular signaling (Akther and Hirase, 2022), behavioral modulation (Nagai et al., 2021a, 2021b), and disease type and progression (Escartin et al., 2021; Burda et al., 2022).

Further understanding the specific contributions of striatal astrocytes to behavioral functions may reveal new therapeutic targets for conditions, such as Huntington's disease (H. G. Lee et al., 2022). Striatal astrocytes have highly context-specific molecular responses in disease, as evidenced by differential changes in gene expression patterns across 14 experimental perturbations (Yu et al., 2020). Chemogenetic stimulation of astrocytic $G_i$-coupled signaling in models of Huntington's disease pathology led to improvements in some, but not all, behavioral symptoms through increased expression of thrombospondin-1. Thus, stimulating $G_i$-coupled receptors in astrocytes could promote synapse formation and may offer a potential therapeutic approach for conditions characterized by synaptic loss (Yu et al., 2020). Future studies should address the complex interactions of astrocytes with neurons and other cell types within the striatum and throughout the cortico-basal ganglia circuits to better understand localized and broader effects of astrocytes in this region.

In summary, astrocytes have essential roles in synaptic transmission, plasticity, and behavioral control in the striatum and amygdala, highlighting the potential importance of astrocytes in the broader landscape of neurologic and neuropsychiatric disorders.

## Astrocytes have context-dependent and multifactorial roles in neurocognitive disorders

Astrocytes are increasingly recognized as having phenotypic diversity and functional versatility (Haustein et al., 2014; Khakh and Sofroniew, 2015; Ben Haim and Rowitch, 2017; Chai et al., 2017; John Lin et al., 2017; Morel et al., 2017; Patani et al., 2023; Soto et al., 2023). As mentioned above, astrocytic features and effects can vary across brain regions and neural circuits. Astrocytes are also affected by brain maturation and aging (Sun et al., 2013; Boisvert et al., 2018; Clarke et al., 2018; Lattke et al., 2021; E. Lee et al., 2022), sex (Bracchi-Ricard et al., 2008; Baier et al., 2022; Krawczyk et al., 2022; Meadows et al., 2022), and genetic variations (Messing et al., 2012; Arnaud et al., 2022), and they are sensitive to sensory processing (Schummers et al., 2008), locomotion (Paukert et al., 2014), arousal (Rasmussen et al., 2023; Reitman et al., 2023; F. Wang et al., 2023), metabolic and dietary cues (Camandola, 2018; Jimenez-Blasco et al., 2020; Nampoothiri et al., 2022; Morant-Ferrando et al., 2023), and stressors, such as sleep deprivation

(Bellesi et al., 2017), social isolation (Cheng et al., 2023), and viral infections (Soung and Klein, 2018; Jorgacevski and Potokar, 2023). It is possible that astrocytes play precise and context-dependent roles as a result of their integrated processing of diverse cues inherent to different biological and environmental contexts.

In brain injury and disease, astrocytic responses are emerging as highly context-dependent. These dynamics are becoming particularly evident in neurodegenerative disorders, including Alzheimer's disease (AD) and related dementias. Astrocytes express or respond to most, if not all, dementia-associated factors (Bruijn et al., 1997; Gu et al., 2010; Serio et al., 2013; Sun et al., 2015; di Domenico et al., 2019; Sadick and Liddelow, 2019; Patani et al., 2023) and show extensive changes in gene expression patterns and functional characteristics depending on age (Soreq et al., 2017; Boisvert et al., 2018; Clarke et al., 2018), type of pathology (Delekate et al., 2014; Orr et al., 2015; Jiang et al., 2016; Liddelow et al., 2017; Giovannoni and Quintana, 2020), and exact brain region (Boisvert et al., 2018; Clarke et al., 2018; Itoh et al., 2018). Indeed, astrocytes have highly diversified transcriptional signatures in different pathologic contexts at least in part because of the combinatorial effects of various transcriptional regulators (Burda et al., 2022).

Astrocytic context specificity is further evident in the cell-autonomous effects of dementia-related proteinopathy on astrocytic gene expression and astrocytic regulation of specific neuronal functions. One of the central pathogenic proteins implicated in neurodegenerative disorders is transactivating response region DNA-binding protein 43 (TDP-43), a multifunctional and ubiquitous DNA/RNA-binding factor that localizes primarily in the nucleus and regulates RNA processing and trafficking, among other functions. In disease, TDP-43 accumulates in the cytoplasm and other subcellular compartments, and is a major component of protein inclusions in amyotrophic lateral sclerosis and frontotemporal dementia (Arai et al., 2006; Neumann et al., 2006; T. J. Cohen et al., 2011). Notably, TDP-43 is also implicated in AD and other conditions that cause behavioral impairments (Amador-Ortiz et al., 2007; Uryu et al., 2008; Davidson et al., 2011; Nag et al., 2015). In addition to its effects in neurons, TDP-43 also affects glial cells and likely promotes disease by multiple mechanisms (Uryu et al., 2008; Diaper et al., 2013; Serio et al., 2013; Uchino et al., 2015; Takeuchi et al., 2016; Paolicelli et al., 2017; Weskamp et al., 2020). In support, aberrant astrocytic cleavage or accumulation of TDP-43 has been detected in amyotrophic lateral sclerosis, frontotemporal dementia, and AD (Serio et al., 2013; Takeuchi et al., 2016; Weskamp et al., 2020; Licht-Murava et al., 2023), but exactly how astrocytic TDP-43 dysregulation affects astrocyte function, astrocytic-neuronal interactions, and behavior was not clear.

New findings by Licht-Murava et al. (2023) indicate that aberrant buildup of TDP-43 in astrocytes is sufficient to cause progressive memory loss, but not other types of behavioral impairments, suggesting that hippocampal astrocytes are more vulnerable to TDP-43 pathology compared with astrocytes in other brain regions. Although hippocampal pathology and dysfunction are prevalent in aging and dementia, exact causes are uncertain and treatment options for neurocognitive decline in dementia are limited. In the context of TDP-43 pathology, Licht-Murava et al. (2023) uncovered abnormal increases in antiviral gene activities in hippocampal astrocytes and excessive production of interferon-inducible chemokines. These chemokines are known to activate $G_i$-coupled CXCR3 receptors, which are typically enriched in
<figure><img src="image_3.png" /><figcaption>**Figure 1.** Newly uncovered astrocytic mechanisms and behavioral effects in health and disease. Simplified summaries of select studies. Refer to the corresponding text and original reports for details. A, Ribot et al. (2021). B, Bohmbach et al. (2022). C, Wahis et al. (2021). D, Yu et al. (2018); Nagai et al. (2019). E, Ju et al. (2022). F, Licht-Murava et al. (2023).</figcaption></figure>

immune cells. However, in TDP-43 pathology, the increases in hippocampal CXCR3 levels were localized to excitatory presynaptic terminals. Chronic stimulation of presynaptic CXCR3 caused aberrant increases in neuronal activities, and genetic ablation of CXCR3 prevented memory loss. Together, these findings reveal that TDP-43-linked increases in astrocytic antiviral signaling and chemokine production can trigger selective neuronal dysregulation and progressive cognitive decline.

Intriguingly, viral infections and other immune challenges can cause changes in memory, mood, and behavior, including sickness behavior and post-acute sequelae of SARS-CoV-2 infection (D'Mello and Swain, 2017; Becker et al., 2021; Damiano et al., 2022; Devlin et al., 2022; Hampshire et al., 2022; Takao and Ohira, 2023). Astrocytic antiviral pathways might contribute to these symptoms in part through increased release of chemokines and other immune response factors (Habbas et al., 2015) that disrupt specific synaptic activities. Of note, CXCR3 blockers have been developed and tested in clinical trials for arthritis and other peripheral inflammatory conditions but have not been assessed in behavioral disorders.

In addition to neuroimmune signaling, metabolic pathways may underlie astrocytic context-specific modulation of neurotransmission and behavior in disease. Astrocytes are crucial for maintaining brain homeostasis and neuronal health in part through astrocytic uptake, processing, and release of various metabolic factors (Belanger et al., 2011; Siracusa et al., 2019). These mechanisms modulate the extracellular environment, control neurotransmitter levels, and regulate energy metabolism. An important component of astrocytic metabolism is the urea cycle, a pathway associated with detoxification of ammonia, a byproduct of amino acid metabolism (P. P. Cohen, 1981; Meijer et al., 1990; Morris, 2002; Gropman et al., 2007).

Recent findings by Ju et al. (2022) have shed new light on the intricate relationship between the urea cycle in astrocytes and their roles in neurotransmission, and reveal how altered astrocyte metabolism can contribute to neurocognitive deficits in disease. In AD patients, astrocytes were found to have increased expression of urea cycle enzymes, including carbamoyl phosphate synthetase-1

and ornithine transcarbamylase, enabling astrocytes to convert toxic ammonia into less harmful byproducts (Ju et al., 2022). Because amyloid-β(Aβ) catabolism results in the production of ammonia, the upregulation of the urea cycle enzymes in AD suggests an adaptive response to the elevated ammonia levels. Ju et al. (2022) found that, although the urea cycle is relatively inactive in healthy astrocytes, it is engaged in AD and linked to the clearance of toxic Aβ aggregates. However, excessive activation of the astrocytic urea cycle was found to disrupt the delicate balance of neurotransmitters, including glutamate and GABA, leading to synaptic dysfunction and memory impairments. In particular, increased urea cycle metabolism led to the production of putrescine via ornithine decarboxylase 1 (ODC1). Subsequently, excessive conversion of putrescine to GABA, an inhibitory neurotransmitter, and hydrogen peroxide (H₂O₂), a toxic byproduct of GABA production in astrocytes, was found to disrupt neurotransmission and impair hippocampal synaptic plasticity, thereby contributing to cognitive decline (Chun et al., 2020).

Targeting astrocytic urea cycle-related mechanisms may hold therapeutic potential for mitigating cognitive deficits in AD. Ju et al. (2022) targeted ODC1 to avoid disrupting the urea cycle, an essential detoxification pathway that promotes Aβ clearance. ODC1 inhibition prevented GABA overproduction and restored memory in mice with AD-linked pathology. Activation of the urea cycle in AD illustrates a context-dependent shift in astrocytic metabolism that also alters neurotransmission and cognition. Furthermore, the duality of the beneficial removal of Aβ with the subsequent detrimental effects of excess putrescine on neurotransmitter balance and memory emphasizes the complexity of astrocytic roles in disease. Understanding the precise mechanisms underlying the interplay between astrocytic urea cycle activity and cognitive decline in AD may inform therapeutic strategies aimed at preserving cognitive function while maintaining ammonia detoxification.

The relationship between astrocytes and the urea cycle represents a fascinating area of research with significant implications for brain metabolism and neurologic health. Elucidating the
<figure><img src="image_3.png" /><figcaption>**Figure 1.** Newly uncovered astrocytic mechanisms and behavioral effects in health and disease. Simplified summaries of select studies. Refer to the corresponding text and original reports for details. A, Ribot et al. (2021). B, Bohmbach et al. (2022). C, Wahis et al. (2021). D, Yu et al. (2018); Nagai et al. (2019). E, Ju et al. (2022). F, Licht-Murava et al. (2023).</figcaption></figure>

immune cells. However, in TDP-43 pathology, the increases in hippocampal CXCR3 levels were localized to excitatory presynaptic terminals. Chronic stimulation of presynaptic CXCR3 caused aberrant increases in neuronal activities, and genetic ablation of CXCR3 prevented memory loss. Together, these findings reveal that TDP-43-linked increases in astrocytic antiviral signaling and chemokine production can trigger selective neuronal dysregulation and progressive cognitive decline.

Intriguingly, viral infections and other immune challenges can cause changes in memory, mood, and behavior, including sickness behavior and post-acute sequelae of SARS-CoV-2 infection (D'Mello and Swain, 2017; Becker et al., 2021; Damiano et al., 2022; Devlin et al., 2022; Hampshire et al., 2022; Takao and Ohira, 2023). Astrocytic antiviral pathways might contribute to these symptoms in part through increased release of chemokines and other immune response factors (Habbas et al., 2015) that disrupt specific synaptic activities. Of note, CXCR3 blockers have been developed and tested in clinical trials for arthritis and other peripheral inflammatory conditions but have not been assessed in behavioral disorders.

In addition to neuroimmune signaling, metabolic pathways may underlie astrocytic context-specific modulation of neurotransmission and behavior in disease. Astrocytes are crucial for maintaining brain homeostasis and neuronal health in part through astrocytic uptake, processing, and release of various metabolic factors (Belanger et al., 2011; Siracusa et al., 2019). These mechanisms modulate the extracellular environment, control neurotransmitter levels, and regulate energy metabolism. An important component of astrocytic metabolism is the urea cycle, a pathway associated with detoxification of ammonia, a byproduct of amino acid metabolism (P. P. Cohen, 1981; Meijer et al., 1990; Morris, 2002; Gropman et al., 2007).

Recent findings by Ju et al. (2022) have shed new light on the intricate relationship between the urea cycle in astrocytes and their roles in neurotransmission, and reveal how altered astrocyte metabolism can contribute to neurocognitive deficits in disease. In AD patients, astrocytes were found to have increased expression of urea cycle enzymes, including carbamoyl phosphate synthetase-1

and ornithine transcarbamylase, enabling astrocytes to convert toxic ammonia into less harmful byproducts (Ju et al., 2022). Because amyloid-β(Aβ) catabolism results in the production of ammonia, the upregulation of the urea cycle enzymes in AD suggests an adaptive response to the elevated ammonia levels. Ju et al. (2022) found that, although the urea cycle is relatively inactive in healthy astrocytes, it is engaged in AD and linked to the clearance of toxic Aβ aggregates. However, excessive activation of the astrocytic urea cycle was found to disrupt the delicate balance of neurotransmitters, including glutamate and GABA, leading to synaptic dysfunction and memory impairments. In particular, increased urea cycle metabolism led to the production of putrescine via ornithine decarboxylase 1 (ODC1). Subsequently, excessive conversion of putrescine to GABA, an inhibitory neurotransmitter, and hydrogen peroxide (H₂O₂), a toxic byproduct of GABA production in astrocytes, was found to disrupt neurotransmission and impair hippocampal synaptic plasticity, thereby contributing to cognitive decline (Chun et al., 2020).

Targeting astrocytic urea cycle-related mechanisms may hold therapeutic potential for mitigating cognitive deficits in AD. Ju et al. (2022) targeted ODC1 to avoid disrupting the urea cycle, an essential detoxification pathway that promotes Aβ clearance. ODC1 inhibition prevented GABA overproduction and restored memory in mice with AD-linked pathology. Activation of the urea cycle in AD illustrates a context-dependent shift in astrocytic metabolism that also alters neurotransmission and cognition. Furthermore, the duality of the beneficial removal of Aβ with the subsequent detrimental effects of excess putrescine on neurotransmitter balance and memory emphasizes the complexity of astrocytic roles in disease. Understanding the precise mechanisms underlying the interplay between astrocytic urea cycle activity and cognitive decline in AD may inform therapeutic strategies aimed at preserving cognitive function while maintaining ammonia detoxification.

The relationship between astrocytes and the urea cycle represents a fascinating area of research with significant implications for brain metabolism and neurologic health. Elucidating the
precise mechanisms and regulation of these interactions may open new avenues for therapeutic interventions. Dysregulation of astrocyte-urea cycle axis has been implicated in several neuro-logic conditions, including hepatic encephalopathy, a neuro-psychiatric disorder associated with liver dysfunction. Notably, metabolic activities in astrocytes and the expression of astrocytic metabolic and mitochondrial genes can be region-specific (Hasel et al., 2021), but it is not clear whether astrocyte metabolism in distinct brain regions responds differently to AD pathology.

Together, these studies suggest that astrocytes can disrupt cognitive function in disease and affect pathology in a context-dependent and dynamic manner through specific changes in neuroimmune and metabolic pathways that influence neu-rotransmission. There is a strong bidirectional relationship between immune responses and metabolism (Tannahill et al., 2013; O'Neill et al., 2016), which may converge on neural mechanisms underlying neurotransmission and cognitive processes. Further unraveling these glial-neuronal molecular networks may be crucial for better understanding and effec-tively treating neurocognitive disorders that involve neuroim-mune and metabolic alterations.

In conclusion, astrocytes are increasingly recognized as active contributors to behavior and cognitive processes. As summarized in Figure 1, new studies have revealed how astrocytes regulate synaptic maturation in the visual cortex and dendritic integra-tion in the hippocampus through context-dependent engage-ment of astrocytic connexins and endocannabinoid pathways, respectively, that affect visual perception and spatial memory (Fig. 1A,B). Moreover, in the amygdala, a subset of astrocytes were found to express OT receptors and selectively modulate anxiety-like behaviors and place preference, and astrocytes in the striatum were found to control synaptic activities through G₁-coupled signaling and modulate attention, hyperactivity, and re-petitive behaviors through multiple molecular mechanisms (Fig. 1C,D). In neuropathological conditions, changes in astrocyte functions can contribute to neurocognitive decline in a pathol-ogy-specific and context-dependent manner. In particular, de-mentia-associated Aβ and TDP-43 proteinopathies were found to alter specific metabolic and neuroimmune pathways in hippo-campal astrocytes that disrupted select aspects of neurotransmis-sion (Fig. 1E,F). Future studies should continue to make use of advanced experimental approaches to gain further insights into the complex and diverse mechanisms by which astrocytes modu-late neural signaling, plasticity, network activities, and behavior. Growing evidence points to astrocyte dysfunction in cognitive and behavioral impairments in a wide range of neurologic and neuropsychiatric disorders, suggesting that new therapeutic strategies that target astrocytes may be useful in the treatment of these disorders.

## References

Ackerman SD, Perez-Catalan NA, Freeman MR, Doe CQ (2021) Astrocytes close a motor circuit critical period. Nature 592:414–420.

Adamsky A, Kol A, Kreisel T, Doron A, Ozeri-Engelhard N, Melcer T, Refaeli R, Horn H, Regev L, Groysman M, London M, Goshen I (2018) Astrocytic activation generates de novo neuronal potentiation and memory enhancement. Cell 174:59–71.e14.

Akther S, Hirase H (2022) Assessment of astrocytes as a mediator of memory and learning in rodents. Glia 70:1484–1505.

Albarran E, Sun Y, Liu Y, Raju K, Dong A, Li Y, Wang S, Sudhof TC, Ding JB (2023) Postsynaptic synucleins mediate endocannabinoid signaling. Nat Neurosci 26:997–1007.

Allen NJ, Eroglu C (2017) Cell biology of astrocyte-synapse interactions. Neuron 96:697–708.

Amador-Ortiz C, Lin WL, Ahmed Z, Personet D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435–445.

Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611.

Arnaud L, Benech P, Greetham L, Stephan D, Jimenez A, Jullien N, Garcia-Gonzalez L, Tsvetkov PO, Devred F, Sancho-Martinez I, Izpisua Belmonte JC, Baranger K, Rivera S, Nivet E (2022) APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-kappaB activation. Cell Rep 40:111200.

Baier MP, Nagaraja RY, Yarbrough HP, Owen DB, Masingale AM, Ranjit R, Stiles MA, Murphy A, Agbaga MP, Ahmad M, Sherry DM, Kinter MT, Van Remmen H, Logan S (2022) Selective ablation of Sod2 in astrocytes induces sex-specific effects on cognitive function, D-serine availability, and astrogliosis. J Neurosci 42:5992–6006.

Baudon A, Clauss Creusot E, Althammer F, Schaaf CP, Charlet A (2022) Emerging role of astrocytes in oxytocin-mediated control of neural circuits and brain functions. Prog Neurobiol 217:102328.

Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, Wisnivesky JP (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 4:e2130645.

Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724–738.

Bellesi M, de Vivo L, Chini M, Gilli F, Tononi G, Cirelli C (2017) Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J Neurosci 37:5263–5273.

Ben Haim L, Rowitch DH (2017) Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci 18:31–41.

Boender AJ, Bontempi L, Nava L, Pelloux Y, Tonini R (2021) Striatal astrocytes shape behavioral flexibility via regulation of the glutamate transporter EAAT2. Biol Psychiatry 89:1045–1057.

Bohmbach K, Masala N, Schonhense EM, Hill K, Haubrich AN, Zimmer A, Opitz T, Beck H, Henneberger C (2022) An astrocytic signaling loop for frequency-dependent control of dendritic integration and spatial learning. Nat Commun 13:7932.

Bohmbach K, Henneberger C, Hirrlinger J (2023) Astrocytes in memory formation and maintenance. Essays Biochem 67:107–117.

Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ (2018) The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep 22:269–285.

Bracchi-Ricard V, Brambilla R, Levenson J, Hu WH, Bramwell A, Sweatt JD, Green EJ, Bethea JR (2008) Astroglial nuclear factor-kappaB regulates learning and memory and synaptic plasticity in female mice. J Neurochem 104:611–623.

Brandebura AN, Paumier A, Onur TS, Allen NJ (2023) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 24:23–39.

Brujin LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327–338.

Burda JE, O'Shea TM, Ao Y, Suresh KB, Wang S, Bernstein AM, Chandra A, Deverasetty S, Kawaguchi R, Kim JH, McCallum S, Rogers A, Wahane S, Sofroniew MV (2022) Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature 606:557–564.

Burguiere E, Monteiro P, Mallet L, Feng G, Graybiel AM (2015) Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol 30:59–65.

Camandola S (2018) Astrocytes, emerging stars of energy homeostasis. Cell Stress 2:246–252.

Chai H, Diaz-Castro B, Shigetomi E, Monte E, Octeau JC, Yu X, Cohn W, Rajendran PS, Vondriska TM, Whitelegge JP, Coppola G, Khakh BS (2017) Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron 95:531–549.e539.

Cheng YT, Woo J, Luna-Figueroa E, Maleki E, Harmanci AS, Deneen B (2023) Social deprivation induces astrocytic TRPA1-GABA suppression of hippocampal circuits. Neuron 111:1301–1315.e1305.
precise mechanisms and regulation of these interactions may open new avenues for therapeutic interventions. Dysregulation of astrocyte-urea cycle axis has been implicated in several neuro-logic conditions, including hepatic encephalopathy, a neuro-psychiatric disorder associated with liver dysfunction. Notably, metabolic activities in astrocytes and the expression of astrocytic metabolic and mitochondrial genes can be region-specific (Hasel et al., 2021), but it is not clear whether astrocyte metabolism in distinct brain regions responds differently to AD pathology.

Together, these studies suggest that astrocytes can disrupt cognitive function in disease and affect pathology in a context-dependent and dynamic manner through specific changes in neuroimmune and metabolic pathways that influence neuro-transmission. There is a strong bidirectional relationship between immune responses and metabolism (Tannahill et al., 2013; O'Neill et al., 2016), which may converge on neural mechanisms underlying neurotransmission and cognitive processes. Further unraveling these glial-neuronal molecular networks may be crucial for better understanding and effectively treating neurocognitive disorders that involve neuroimmune and metabolic alterations.

In conclusion, astrocytes are increasingly recognized as active contributors to behavior and cognitive processes. As summarized in Figure 1, new studies have revealed how astrocytes regulate synaptic maturation in the visual cortex and dendritic integration in the hippocampus through context-dependent engagement of astrocytic connexins and endocannabinoid pathways, respectively, that affect visual perception and spatial memory (Fig. 1A,B). Moreover, in the amygdala, a subset of astrocytes were found to express OT receptors and selectively modulate anxiety-like behaviors and place preference, and astrocytes in the striatum were found to control synaptic activities through G₁-coupled signaling and modulate attention, hyperactivity, and repetitive behaviors through multiple molecular mechanisms (Fig. 1C,D). In neuropathological conditions, changes in astrocyte functions can contribute to neurocognitive decline in a pathology-specific and context-dependent manner. In particular, dementia-associated Aβ and TDP-43 proteinopathies were found to alter specific metabolic and neuroimmune pathways in hippocampal astrocytes that disrupted select aspects of neurotransmission (Fig. 1E,F). Future studies should continue to make use of advanced experimental approaches to gain further insights into the complex and diverse mechanisms by which astrocytes modulate neural signaling, plasticity, network activities, and behavior. Growing evidence points to astrocyte dysfunction in cognitive and behavioral impairments in a wide range of neurologic and neuropsychiatric disorders, suggesting that new therapeutic strategies that target astrocytes may be useful in the treatment of these disorders.

## References

* Ackerman SD, Perez-Catalan NA, Freeman MR, Doe CQ (2021) Astrocytes close a motor circuit critical period. Nature 592:414–420.

* Adamsky A, Kol A, Kreisel T, Doron A, Ozeri-Engelhard N, Melcer T, Refaeli R, Horn H, Regev L, Groysman M, London M, Goshen I (2018) Astrocytic activation generates de novo neuronal potentiation and memory enhancement. Cell 174:59–71.e14.

* Akther S, Hirase H (2022) Assessment of astrocytes as a mediator of memory and learning in rodents. Glia 70:1484–1505.

* Albarran E, Sun Y, Liu Y, Raju K, Dong A, Li Y, Wang S, Sudhof TC, Ding JB (2023) Postsynaptic synucleins mediate endocannabinoid signaling. Nat Neurosci 26:997–1007.

* Allen NJ, Eroglu C (2017) Cell biology of astrocyte-synapse interactions. Neuron 96:697–708.

* Amador-Ortiz C, Lin WL, Ahmed Z, Personet D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435–445.

* Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611.

* Arnaud L, Benech P, Greetham L, Stephan D, Jimenez A, Jullien N, Garcia-Gonzalez L, Tsvetkov PO, Devred F, Sancho-Martinez I, Izpisua Belmonte JC, Baranger K, Rivera S, Nivet E (2022) APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-kappaB activation. Cell Rep 40:111200.

* Baier MP, Nagaraja RY, Yarbrough HP, Owen DB, Masingale AM, Ranjit R, Stiles MA, Murphy A, Agbaga MP, Ahmad M, Sherry DM, Kinter MT, Van Remmen H, Logan S (2022) Selective ablation of Sod2 in astrocytes induces sex-specific effects on cognitive function, D-serine availability, and astrogliosis. J Neurosci 42:5992–6006.

* Baudon A, Clauss Creusot E, Althammer F, Schaaf CP, Charlet A (2022) Emerging role of astrocytes in oxytocin-mediated control of neural circuits and brain functions. Prog Neurobiol 217:102328.

* Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, Wisnivesky JP (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 4:e2130645.

* Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724–738.

* Bellesi M, de Vivo L, Chini M, Gilli F, Tononi G, Cirelli C (2017) Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J Neurosci 37:5263–5273.

* Ben Haim L, Rowitch DH (2017) Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci 18:31–41.

* Boender AJ, Bontempi L, Nava L, Pelloux Y, Tonini R (2021) Striatal astrocytes shape behavioral flexibility via regulation of the glutamate transporter EAAT2. Biol Psychiatry 89:1045–1057.

* Bohmbach K, Masala N, Schonhense EM, Hill K, Haubrich AN, Zimmer A, Opitz T, Beck H, Henneberger C (2022) An astrocytic signaling loop for frequency-dependent control of dendritic integration and spatial learning. Nat Commun 13:7932.

* Bohmbach K, Henneberger C, Hirrlinger J (2023) Astrocytes in memory formation and maintenance. Essays Biochem 67:107–117.

* Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ (2018) The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep 22:269–285.

* Bracchi-Ricard V, Brambilla R, Levenson J, Hu WH, Bramwell A, Sweatt JD, Green EJ, Bethea JR (2008) Astroglial nuclear factor-kappaB regulates learning and memory and synaptic plasticity in female mice. J Neurochem 104:611–623.

* Brandebura AN, Paumier A, Onur TS, Allen NJ (2023) Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 24:23–39.

* Brujin LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327–338.

* Burda JE, O'Shea TM, Ao Y, Suresh KB, Wang S, Bernstein AM, Chandra A, Deverasetty S, Kawaguchi R, Kim JH, McCallum S, Rogers A, Wahane S, Sofroniew MV (2022) Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature 606:557–564.

* Burguiere E, Monteiro P, Mallet L, Feng G, Graybiel AM (2015) Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol 30:59–65.

* Camandola S (2018) Astrocytes, emerging stars of energy homeostasis. Cell Stress 2:246–252.

* Chai H, Diaz-Castro B, Shigetomi E, Monte E, Octeau JC, Yu X, Cohn W, Rajendran PS, Vondriska TM, Whitelegge JP, Coppola G, Khakh BS (2017) Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron 95:531–549.e539.

* Cheng YT, Woo J, Luna-Figueroa E, Maleki E, Harmanci AS, Deneen B (2023) Social deprivation induces astrocytic TRPA1-GABA suppression of hippocampal circuits. Neuron 111:1301–1315.e1305.
Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461–472.

Chipman PH, Fung CC, Pazo Fernandez A, Sawant A, Tedoldi A, Kawai A, Ghimire Gautam S, Kurosawa M, Abe M, Sakimura K, Fukai T, Goda Y (2021) Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum. Elife 10:e70818.

Chun H, et al. (2020) Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via H(2)O(2)(−) production. Nat Neurosci 23:1555–1566.

Chung WS, Welsh CA, Barres BA, Stevens B (2015) Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 18:1539–1545.

Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, Joung J, Foo LC, Thompson A, Chen C, Smith SJ, Barres BA (2013) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504:394–400.

Clarke LE, Barres BA (2013) Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci 14:311–321.

Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA (2018) Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci USA 115:E1896–E1905.

Cohen PP (1981) The ornithine-urea cycle: biosynthesis and regulation of carbamyl phosphate synthetase I and ornithine transcarbamylase. Curr Top Cell Regul 18:1–19.

Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17:659–667.

Corkrum M, Covelo A, Lines J, Bellocchio L, Pisansky M, Loke K, Quintana R, Rothwell PE, Lujan R, Marsicano G, Martin ED, Thomas MJ, Kofuji P, Araque A (2020) Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity. Neuron 105:1036–1047.e1035.

Covelo A, Eraso-Pichot A, Fernandez-Moncada I, Serrat R, Marsicano G (2021) CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions. Neuropharmacology 195:108678.

Curreli S, Bonato J, Romanzi S, Panzeri S, Fellin T (2022) Complementary encoding of spatial information in hippocampal astrocytes. PLoS Biol 20:e3001530.

D'Mello C, Swain MG (2017) Immune-to-brain communication pathways in inflammation-associated sickness and depression. Curr Top Behav Neurosci 31:73–94.

Damiano RF, Guedes BF, de Rocca CC, de Padua Serafim A, Castro LH, Munhoz CD, Nitrini R, Filho GB, Miguel EC, Lucchetti G, Forlenza O (2022) Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 272:139–154.

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703–713.

De Strooper B, Karran E (2016) The cellular phase of Alzheimer's disease. Cell 164:603–615.

Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC (2014) Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model. Nat Commun 5:5422.

Devlin BA, Smith CJ, Bilbo SD (2022) Sickness and the social brain: how the immune system regulates behavior across species. Brain Behav Evol 97:197–210.

Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D, Tiret P, Volterra A (2011) Local Ca²⁺ detection and modulation of synaptic release by astrocytes. Nat Neurosci 14:1276–1284.

di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease. Stem Cell Rep 12:213–229.

Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521–528.

Diaper DC, Adachi Y, Lazarou L, Greenstein M, Simoes FA, Di Domenico A, Solomon DA, Lowe S, Alsubaie R, Cheng D, Buckley S, Humphrey DM, Shaw CE, Hirth F (2013) *Drosophila* TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet 22:3883–3893.

Doron A, Rubin A, Benmelech-Chovav A, Benaim N, Carmi T, Refaeli R, Novick N, Kreisel T, Ziv Y, Goshen I (2022) Hippocampal astrocytes encode reward location. Nature 609:772–778.

Dubruc F, Dupret D, Caillard O (2013) Self-tuning of inhibition by endocannabinoids shapes spike-time precision in CA1 pyramidal neurons. J Neurophysiol 110:1930–1944.

Eliava M, et al. (2016) A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron 89:1291–1304.

Endo F, Kasai A, Soto JS, Yu X, Qu Z, Hashimoto H, Gradinaru V, Kawaguchi R, Khakh BS (2022) Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science 378:eadc9020.

Escartin C, et al. (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312–325.

Fortin DA, Trettel J, Levine ES (2004) Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92:2105–2112.

Gao V, Suzuki A, Magistretti PJ, Lengacher S, Pollonini G, Steinman MQ, Alberini CM (2016) Astrocytic beta2-adrenergic receptors mediate hippocampal long-term memory consolidation. Proc Natl Acad Sci USA 113:8526–8531.

Geiller T, Priestley JB, Losonczy A (2023) A local circuit-basis for spatial navigation and memory processes in hippocampal area CA1. Curr Opin Neurobiol 79:102701.

Giovannoni F, Quintana FJ (2020) The role of astrocytes in CNS inflammation. Trends Immunol 41:805–819.

Gomez-Gonzalo M, Navarrete M, Perea G, Covelo A, Martin-Fernandez M, Shigemoto R, Lujan R, Araque A (2015) Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission. Cereb Cortex 25:3699–3712.

Graybiel AM (2008) Habits, rituals, and the evaluative brain. Annu Rev Neurosci 31:359–387.

Graybiel AM, Grafton ST (2015) The striatum: where skills and habits meet. Cold Spring Harb Perspect Biol 7:a021691.

Grienberger C, Chen X, Konnerth A (2014) NMDA receptor-dependent multidendrite Ca(2+) spikes required for hippocampal burst firing in vivo. Neuron 81:1274–1281.

Gropman AL, Summar M, Leonard JV (2007) Neurological implications of urea cycle disorders. J Inherit Metab Dis 30:865–879.

Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 3:12.

Habbas S, Santello M, Becker D, Stubbe H, Zappia G, Liaudet N, Klaus FR, Kollias G, Fontana A, Pryce CR, Suter T, Volterra A (2015) Neuroinflammatory TNFalpha impairs memory via astrocyte signaling. Cell 163:1730–1741.

Hampshire A, et al., Cambridge NeuroCOVID Group, the NIHR COVID-19 BioResource, and Cambridge NIHR Clinical Research Facility (2022) Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine 47:101417.

Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F, Koehl M, Abrous DN, Mendizabal-Zubiaga J, Grandes P, Liu Q, Bai G, Wang W, Xiong L, Ren W, Marsicano G, Zhang X (2012) Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148:1039–1050.

Harnett MT, Magee JC, Williams SR (2015) Distribution and function of HCN channels in the apical dendritic tuft of neocortical pyramidal neurons. J Neurosci 35:1024–1037.

Hasan MT, et al. (2019) A fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103:133–146.e138.

Hasel P, Rose IV, Sadick JS, Kim RD, Liddelow SA (2021) Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci 24:1475–1487.

Haustein MD, Kracun S, Lu XH, Shih T, Jackson-Weaver O, Tong X, Xu J, Yang XW, O'Dell TJ, Marvin JS, Ellisman MH, Bushong EA, Looger LL,
Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461–472.

Chipman PH, Fung CC, Pazo Fernandez A, Sawant A, Tedoldi A, Kawai A, Ghimire Gautam S, Kurosawa M, Abe M, Sakimura K, Fukai T, Goda Y (2021) Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum. Elife 10:e70818.

Chun H, et al. (2020) Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via H(2)O(2)(−) production. Nat Neurosci 23:1555–1566.

Chung WS, Welsh CA, Barres BA, Stevens B (2015) Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 18:1539–1545.

Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, Joung J, Foo LC, Thompson A, Chen C, Smith SJ, Barres BA (2013) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504:394–400.

Clarke LE, Barres BA (2013) Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci 14:311–321.

Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA (2018) Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci USA 115:E1896–E1905.

Cohen PP (1981) The ornithine-urea cycle: biosynthesis and regulation of carbamyl phosphate synthetase I and ornithine transcarbamylase. Curr Top Cell Regul 18:1–19.

Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17:659–667.

Corkrum M, Covelo A, Lines J, Bellocchio L, Pisansky M, Loke K, Quintana R, Rothwell PE, Lujan R, Marsicano G, Martin ED, Thomas MJ, Kofuji P, Araque A (2020) Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity. Neuron 105:1036–1047.e1035.

Covelo A, Eraso-Pichot A, Fernandez-Moncada I, Serrat R, Marsicano G (2021) CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions. Neuropharmacology 195:108678.

Curreli S, Bonato J, Romanzi S, Panzeri S, Fellin T (2022) Complementary encoding of spatial information in hippocampal astrocytes. PLoS Biol 20:e3001530.

D'Mello C, Swain MG (2017) Immune-to-brain communication pathways in inflammation-associated sickness and depression. Curr Top Behav Neurosci 31:73–94.

Damiano RF, Guedes BF, de Rocca CC, de Padua Serafim A, Castro LH, Munhoz CD, Nitrini R, Filho GB, Miguel EC, Lucchetti G, Forlenza O (2022) Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 272:139–154.

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703–713.

De Strooper B, Karran E (2016) The cellular phase of Alzheimer's disease. Cell 164:603–615.

Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC (2014) Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model. Nat Commun 5:5422.

Devlin BA, Smith CJ, Bilbo SD (2022) Sickness and the social brain: how the immune system regulates behavior across species. Brain Behav Evol 97:197–210.

Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D, Tiret P, Volterra A (2011) Local Ca²⁺ detection and modulation of synaptic release by astrocytes. Nat Neurosci 14:1276–1284.

di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease. Stem Cell Rep 12:213–229.

Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521–528.

Diaper DC, Adachi Y, Lazarou L, Greenstein M, Simoes FA, Di Domenico A, Solomon DA, Lowe S, Alsubaie R, Cheng D, Buckley S, Humphrey DM, Shaw CE, Hirth F (2013) *Drosophila* TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet 22:3883–3893.

Doron A, Rubin A, Benmelech-Chovav A, Benaim N, Carmi T, Refaeli R, Novick N, Kreisel T, Ziv Y, Goshen I (2022) Hippocampal astrocytes encode reward location. Nature 609:772–778.

Dubruc F, Dupret D, Caillard O (2013) Self-tuning of inhibition by endocannabinoids shapes spike-time precision in CA1 pyramidal neurons. J Neurophysiol 110:1930–1944.

Eliava M, et al. (2016) A new population of parvocellular oxytocin neurons controlling magnocellular neuron activity and inflammatory pain processing. Neuron 89:1291–1304.

Endo F, Kasai A, Soto JS, Yu X, Qu Z, Hashimoto H, Gradinaru V, Kawaguchi R, Khakh BS (2022) Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science 378:eadc9020.

Escartin C, et al. (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312–325.

Fortin DA, Trettel J, Levine ES (2004) Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92:2105–2112.

Gao V, Suzuki A, Magistretti PJ, Lengacher S, Pollonini G, Steinman MQ, Alberini CM (2016) Astrocytic beta2-adrenergic receptors mediate hippocampal long-term memory consolidation. Proc Natl Acad Sci USA 113:8526–8531.

Geiller T, Priestley JB, Losonczy A (2023) A local circuit-basis for spatial navigation and memory processes in hippocampal area CA1. Curr Opin Neurobiol 79:102701.

Giovannoni F, Quintana FJ (2020) The role of astrocytes in CNS inflammation. Trends Immunol 41:805–819.

Gomez-Gonzalo M, Navarrete M, Perea G, Covelo A, Martin-Fernandez M, Shigemoto R, Lujan R, Araque A (2015) Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission. Cereb Cortex 25:3699–3712.

Graybiel AM (2008) Habits, rituals, and the evaluative brain. Annu Rev Neurosci 31:359–387.

Graybiel AM, Grafton ST (2015) The striatum: where skills and habits meet. Cold Spring Harb Perspect Biol 7:a021691.

Grienberger C, Chen X, Konnerth A (2014) NMDA receptor-dependent multidendrite Ca(2+) spikes required for hippocampal burst firing in vivo. Neuron 81:1274–1281.

Gropman AL, Summar M, Leonard JV (2007) Neurological implications of urea cycle disorders. J Inherit Metab Dis 30:865–879.

Gu XL, Long CX, Sun L, Xie C, Lin X, Cai H (2010) Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 3:12.

Habbas S, Santello M, Becker D, Stubbe H, Zappia G, Liaudet N, Klaus FR, Kollias G, Fontana A, Pryce CR, Suter T, Volterra A (2015) Neuroinflammatory TNFalpha impairs memory via astrocyte signaling. Cell 163:1730–1741.

Hampshire A, et al., Cambridge NeuroCOVID Group, the NIHR COVID-19 BioResource, and Cambridge NIHR Clinical Research Facility (2022) Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine 47:101417.

Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F, Koehl M, Abrous DN, Mendizabal-Zubiaga J, Grandes P, Liu Q, Bai G, Wang W, Xiong L, Ren W, Marsicano G, Zhang X (2012) Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148:1039–1050.

Harnett MT, Magee JC, Williams SR (2015) Distribution and function of HCN channels in the apical dendritic tuft of neocortical pyramidal neurons. J Neurosci 35:1024–1037.

Hasan MT, et al. (2019) A fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103:133–146.e138.

Hasel P, Rose IV, Sadick JS, Kim RD, Liddelow SA (2021) Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci 24:1475–1487.

Haustein MD, Kracun S, Lu XH, Shih T, Jackson-Weaver O, Tong X, Xu J, Yang XW, O'Dell TJ, Marvin JS, Ellisman MH, Bushong EA, Looger LL,
Khakh BS (2014) Conditions and constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. Neuron 82:413–429.

Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term potentiation depends on release of D-serine from astrocytes. Nature 463:232–236.

Hensch TK (2005) Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6:877–888.

Itoh N, Itoh Y, Tassoni A, Ren E, Kaito M, Ohno A, Ao Y, Farkhondeh V, Johnsonbaugh H, Burda J, Sofroniew MV, Voskuhl RR (2018) Cell-specific and region-specific transcriptomics in the multiple sclerosis model: focus on astrocytes. Proc Natl Acad Sci USA 115:E302–E309.

Iwasaki M, et al. (2023) An analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray in rats. Nat Commun 14:1066.

Jiang R, Diaz-Castro B, Looger LL, Khakh BS (2016) Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice. J Neurosci 36:3453–3470.

Jimenez-Blasco D, et al. (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature 583:603–608.

John Lin CC, Yu K, Hatcher A, Huang TW, Lee HK, Carlson J, Weston MC, Chen F, Zhang Y, Zhu W, Mohila CA, Ahmed N, Patel AJ, Arenkiel BR, Noebels JL, Creighton CJ, Deneen B (2017) Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci 20:396–405.

Jorgacevski J, Potokar M (2023) Immune functions of astrocytes in viral neuroinfections. Int J Mol Sci 24:3514.

Ju YH, Bhalla M, Hyeon SJ, Oh JE, Yoo S, Chae U, Kwon J, Koh W, Lim J, Park YM, Lee J, Cho IJ, Lee H, Ryu H, Lee CJ (2022) Astrocytic urea cycle detoxifies Abeta-derived ammonia while impairing memory in Alzheimer's disease. Cell Metab 34:1104–1120.e1108.

Jurek B, Neumann ID (2018) The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev 98:1805–1908.

Kang S, Hong SI, Lee J, Peyton L, Baker M, Choi S, Kim H, Chang SY, Choi DS (2020) Activation of astrocytes in the dorsomedial striatum facilitates transition from habitual to goal-directed reward-seeking behavior. Biol Psychiatry 88:797–808.

Khakh BS (2019) Astrocyte-neuron interactions in the striatum: insights on identity, form, and function. Trends Neurosci 42:617–630.

Khakh BS, Deneen B (2019) The emerging nature of astrocyte diversity. Annu Rev Neurosci 42:187–207.

Khakh BS, Sofroniew MV (2015) Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18:942–952.

Kofuji P, Araque A (2021) Astrocytes and behavior. Annu Rev Neurosci 44:49–67.

Krawczyk MC, et al. (2022) Human astrocytes exhibit tumor microenvironment-, age-, and sex-related transcriptomic signatures. J Neurosci 42:1587–1603.

Lattke M, Goldstone R, Ellis JK, Boeing S, Jurado-Arjona J, Marichal N, MacRae JI, Berninger B, Guillemot F (2021) Extensive transcriptional and chromatin changes underlie astrocyte maturation in vivo and in culture. Nat Commun 12:4335.

Lee E, Jung YJ, Park YR, Lim S, Choi YJ, Lee SY, Kim CH, Mun JY, Chung WS (2022) A distinct astrocyte subtype in the aging mouse brain characterized by impaired protein homeostasis. Nat Aging 2:726–741.

Lee HG, Wheeler MA, Quintana FJ (2022) Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov 21:339–358.

Lee HS, Ghetti A, Pinto-Duarte A, Wang X, Dziewczapolski G, Galimi F, Huitron-Resendiz S, Pina-Crespo JC, Roberts AJ, Verma IM, Sejnowski TJ, Heinemann SF (2014) Astrocytes contribute to gamma oscillations and recognition memory. Proc Natl Acad Sci USA 111:E3343–E3352.

Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL, Orr AG (2023) Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines. Sci Adv 9:eade1282.

Liddelow SA, et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487.

Losonczy A, Magee JC (2006) Integrative properties of radial oblique dendrites in hippocampal CA1 pyramidal neurons. Neuron 50:291–307.

Markowitz JE, Gillis WF, Beron CC, Neufeld SQ, Robertson K, Bhagat ND, Peterson RE, Peterson E, Hyun M, Linderman SW, Sabatini BL, Datta SR (2018) The striatum organizes 3D behavior via moment-to-moment action selection. Cell 174:44–58.e17.

Meadows SM, Palaguachi F, Licht-Murava A, Barnett D, Zimmer TS, Zhou C, McDonough SR, Orr AL, Orr AG (2022) Astrocytes regulate spatial

memory in a sex-specific manner. bioRxiv 511881. https://doi.org/10.1101/2022.11.03.511881.

Meijer AJ, Lamers WH, Chamuleau RA (1990) Nitrogen metabolism and ornithine cycle function. Physiol Rev 70:701–748.

Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE (2012) Alexander disease. J Neurosci 32:5017–5023.

Min R, Nevian T (2012) Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci 15:746–753.

Molofsky AV, Krencik R, Ullian EM, Tsai HH, Deneen B, Richardson WD, Barres BA, Rowitch DH (2012) Astrocytes and disease: a neurodevelopmental perspective. Genes Dev 26:891–907.

Morant-Ferrando B, Jimenez-Blasco D, Alonso-Batan P, Agulla J, Lapresa R, Garcia-Rodriguez D, Yunta-Sanchez S, Lopez-Fabuel I, Fernandez E, Carmeliet P, Almeida A, Garcia-Macia M, Bolanos JP (2023) Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition. Nat Metab 5:1290–1302.

Morel L, Chiang MS, Higashimori H, Shoneye T, Iyer LK, Yelick J, Tai A, Yang Y (2017) Molecular and functional properties of regional astrocytes in the adult brain. J Neurosci 37:8706–8717.

Morris SM Jr (2002) Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 22:87–105.

Muller CM, Best J (1989) Ocular dominance plasticity in adult cat visual cortex after transplantation of cultured astrocytes. Nature 342:427–430.

Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA, Schneider JA (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol 77:942–952.

Nagai J, Rajbhandari AK, Gangwani MR, Hachisuka A, Coppola G, Masmanidis SC, Fanselow MS, Khakh BS (2019) Hyperactivity with disrupted attention by activation of an astrocyte synaptogenic cue. Cell 177:1280–1292.e1220.

Nagai J, Yu X, Papouin T, Cheong E, Freeman MR, Monk KR, Hastings MH, Haydon PG, Rowitch D, Shaham S, Khakh BS (2021a) Behaviorally consequential astrocytic regulation of neural circuits. Neuron 109:576–596.

Nagai J, Bellafard A, Qu Z, Yu X, Ollivier M, Gangwani MR, Diaz-Castro B, Coppola G, Schumacher SM, Golshani P, Gradinaru V, Khakh BS (2021b) Specific and behaviorally consequential astrocyte G(q) GPCR signaling attenuation in vivo with ibetaARK. Neuron 109:2256–2274.e2259.

Nampoothiri S, Nogueiras R, Schwaninger M, Prevot V (2022) Glial cells as integrators of peripheral and central signals in the regulation of energy homeostasis. Nat Metab 4:813–825.

Navarrete M, Araque A (2008) Endocannabinoids mediate neuron-astrocyte communication. Neuron 57:883–893.

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Maslih E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133.

O'Keeffe J, Dostrovsky J (1971) The hippocampus as a spatial map: preliminary evidence from unit activity in the freely-moving rat. Brain Res 34:171–175.

O'Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553–565.

Orr AG, Hsiao EC, Wang MM, Ho K, Kim DH, Wang X, Guo W, Kang J, Yu GQ, Adame A, Devidze N, Dubal DB, Maslih E, Conklin BR, Mucke L (2015) Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nat Neurosci 18:423–434.

Panatier A, Vallee J, Haber M, Murai KK, Lacaille JC, Robitaille R (2011) Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146:785–798.

Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L (2017) TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95:297–308.e296.

Papouin T, Dunphy JM, Tolman M, Dineley KT, Haydon PG (2017) Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness. Neuron 94:840–854.e847.

Patani R, Hardingham GE, Liddelow SA (2023) Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol 19:395–409.

Paukert M, Agarwal A, Cha J, Doze VA, Kang JU, Bergles DE (2014) Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron 82:1263–1270.
Khakh BS (2014) Conditions and constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. Neuron 82:413–429.

Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term potentiation depends on release of D-serine from astrocytes. Nature 463:232–236.

Hensch TK (2005) Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6:877–888.

Itoh N, Itoh Y, Tassoni A, Ren E, Kaito M, Ohno A, Ao Y, Farkhondeh V, Johnsonbaugh H, Burda J, Sofroniew MV, Voskuhl RR (2018) Cell-specific and region-specific transcriptomics in the multiple sclerosis model: focus on astrocytes. Proc Natl Acad Sci USA 115:E302–E309.

Iwasaki M, et al. (2023) An analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray in rats. Nat Commun 14:1066.

Jiang R, Diaz-Castro B, Looger LL, Khakh BS (2016) Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice. J Neurosci 36:3453–3470.

Jimenez-Blasco D, et al. (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature 583:603–608.

John Lin CC, Yu K, Hatcher A, Huang TW, Lee HK, Carlson J, Weston MC, Chen F, Zhang Y, Zhu W, Mohila CA, Ahmed N, Patel AJ, Arenkiel BR, Noebels JL, Creighton CJ, Deneen B (2017) Identification of diverse astrocyte populations and their malignant analogs. Nat Neurosci 20:396–405.

Jorgacevski J, Potokar M (2023) Immune functions of astrocytes in viral neuroinfections. Int J Mol Sci 24:3514.

Ju YH, Bhalla M, Hyeon SJ, Oh JE, Yoo S, Chae U, Kwon J, Koh W, Lim J, Park YM, Lee J, Cho IJ, Lee H, Ryu H, Lee CJ (2022) Astrocytic urea cycle detoxifies Abeta-derived ammonia while impairing memory in Alzheimer's disease. Cell Metab 34:1104–1120.e1108.

Jurek B, Neumann ID (2018) The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev 98:1805–1908.

Kang S, Hong SI, Lee J, Peyton L, Baker M, Choi S, Kim H, Chang SY, Choi DS (2020) Activation of astrocytes in the dorsomedial striatum facilitates transition from habitual to goal-directed reward-seeking behavior. Biol Psychiatry 88:797–808.

Khakh BS (2019) Astrocyte-neuron interactions in the striatum: insights on identity, form, and function. Trends Neurosci 42:617–630.

Khakh BS, Deneen B (2019) The emerging nature of astrocyte diversity. Annu Rev Neurosci 42:187–207.

Khakh BS, Sofroniew MV (2015) Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18:942–952.

Kofuji P, Araque A (2021) Astrocytes and behavior. Annu Rev Neurosci 44:49–67.

Krawczyk MC, et al. (2022) Human astrocytes exhibit tumor microenvironment-, age-, and sex-related transcriptomic signatures. J Neurosci 42:1587–1603.

Lattke M, Goldstone R, Ellis JK, Boeing S, Jurado-Arjona J, Marichal N, MacRae JI, Berninger B, Guillemot F (2021) Extensive transcriptional and chromatin changes underlie astrocyte maturation in vivo and in culture. Nat Commun 12:4335.

Lee E, Jung YJ, Park YR, Lim S, Choi YJ, Lee SY, Kim CH, Mun JY, Chung WS (2022) A distinct astrocyte subtype in the aging mouse brain characterized by impaired protein homeostasis. Nat Aging 2:726–741.

Lee HG, Wheeler MA, Quintana FJ (2022) Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov 21:339–358.

Lee HS, Ghetti A, Pinto-Duarte A, Wang X, Dziewczapolski G, Galimi F, Huitron-Resendiz S, Pina-Crespo JC, Roberts AJ, Verma IM, Sejnowski TJ, Heinemann SF (2014) Astrocytes contribute to gamma oscillations and recognition memory. Proc Natl Acad Sci USA 111:E3343–E3352.

Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL, Orr AG (2023) Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines. Sci Adv 9:eade1282.

Liddelow SA, et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487.

Losonczy A, Magee JC (2006) Integrative properties of radial oblique dendrites in hippocampal CA1 pyramidal neurons. Neuron 50:291–307.

Markowitz JE, Gillis WF, Beron CC, Neufeld SQ, Robertson K, Bhagat ND, Peterson RE, Peterson E, Hyun M, Linderman SW, Sabatini BL, Datta SR (2018) The striatum organizes 3D behavior via moment-to-moment action selection. Cell 174:44–58.e17.

Meadows SM, Palaguachi F, Licht-Murava A, Barnett D, Zimmer TS, Zhou C, McDonough SR, Orr AL, Orr AG (2022) Astrocytes regulate spatial

memory in a sex-specific manner. bioRxiv 511881. https://doi.org/10.1101/2022.11.03.511881.

Meijer AJ, Lamers WH, Chamuleau RA (1990) Nitrogen metabolism and ornithine cycle function. Physiol Rev 70:701–748.

Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE (2012) Alexander disease. J Neurosci 32:5017–5023.

Min R, Nevian T (2012) Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci 15:746–753.

Molofsky AV, Krencik R, Ullian EM, Tsai HH, Deneen B, Richardson WD, Barres BA, Rowitch DH (2012) Astrocytes and disease: a neurodevelopmental perspective. Genes Dev 26:891–907.

Morant-Ferrando B, Jimenez-Blasco D, Alonso-Batan P, Agulla J, Lapresa R, Garcia-Rodriguez D, Yunta-Sanchez S, Lopez-Fabuel I, Fernandez E, Carmeliet P, Almeida A, Garcia-Macia M, Bolanos JP (2023) Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition. Nat Metab 5:1290–1302.

Morel L, Chiang MS, Higashimori H, Shoneye T, Iyer LK, Yelick J, Tai A, Yang Y (2017) Molecular and functional properties of regional astrocytes in the adult brain. J Neurosci 37:8706–8717.

Morris SM Jr (2002) Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 22:87–105.

Muller CM, Best J (1989) Ocular dominance plasticity in adult cat visual cortex after transplantation of cultured astrocytes. Nature 342:427–430.

Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA, Schneider JA (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol 77:942–952.

Nagai J, Rajbhandari AK, Gangwani MR, Hachisuka A, Coppola G, Masmanidis SC, Fanselow MS, Khakh BS (2019) Hyperactivity with disrupted attention by activation of an astrocyte synaptogenic cue. Cell 177:1280–1292.e1220.

Nagai J, Yu X, Papouin T, Cheong E, Freeman MR, Monk KR, Hastings MH, Haydon PG, Rowitch D, Shaham S, Khakh BS (2021a) Behaviorally consequential astrocytic regulation of neural circuits. Neuron 109:576–596.

Nagai J, Bellafard A, Qu Z, Yu X, Ollivier M, Gangwani MR, Diaz-Castro B, Coppola G, Schumacher SM, Golshani P, Gradinaru V, Khakh BS (2021b) Specific and behaviorally consequential astrocyte G(q) GPCR signaling attenuation in vivo with ibetaARK. Neuron 109:2256–2274.e2259.

Nampoothiri S, Nogueiras R, Schwaninger M, Prevot V (2022) Glial cells as integrators of peripheral and central signals in the regulation of energy homeostasis. Nat Metab 4:813–825.

Navarrete M, Araque A (2008) Endocannabinoids mediate neuron-astrocyte communication. Neuron 57:883–893.

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133.

O'Keeffe J, Dostrovsky J (1971) The hippocampus as a spatial map: preliminary evidence from unit activity in the freely-moving rat. Brain Res 34:171–175.

O'Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553–565.

Orr AG, Hsiao EC, Wang MM, Ho K, Kim DH, Wang X, Guo W, Kang J, Yu GQ, Adame A, Devidze N, Dubal DB, Masliah E, Conklin BR, Mucke L (2015) Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nat Neurosci 18:423–434.

Panatier A, Vallee J, Haber M, Murai KK, Lacaille JC, Robitaille R (2011) Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146:785–798.

Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L (2017) TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95:297–308.e296.

Papouin T, Dunphy JM, Tolman M, Dineley KT, Haydon PG (2017) Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness. Neuron 94:840–854.e847.

Patani R, Hardingham GE, Liddelow SA (2023) Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol 19:395–409.

Paukert M, Agarwal A, Cha J, Doze VA, Kang JU, Bergles DE (2014) Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron 82:1263–1270.
Perea G, Araque A (2005) Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. *J Neurosci* 25:2192–2203.

Perea G, Araque A (2007) Astrocytes potentiate transmitter release at single hippocampal synapses. *Science* 317:1083–1086.

Rasmussen RN, Asiminas A, Carlsen EM, Kjaerby C, Smith NA (2023) Astrocytes: integrators of arousal state and sensory context. *Trends Neurosci* 46:418–425.

Reitman ME, Tse V, Mi X, Willoughby DD, Peinado A, Aivazidis A, Myagmar BE, Simpson PC, Bayraktar OA, Yu G, Poskanzer KE (2023) Norepinephrine links astrocytic activity to regulation of cortical state. *Nat Neurosci* 26:579–593.

Remy S, Spruston N (2007) Dendritic spikes induce single-burst long-term potentiation. *Proc Natl Acad Sci USA* 104:17192–17197.

Ribot J, Breton R, Calvo CF, Moulard J, Ezan P, Zapata J, Samama K, Moreau M, Bemelmans AP, Sabatet V, Dingli F, Loew D, Milleret C, Billuart P, Dallerac G, Rouach N (2021) Astrocytes close the mouse critical period for visual plasticity. *Science* 373:77–81.

Robin LM, et al. (2018) Astroglial CB₁ receptors determine synaptic D-serine availability to enable recognition memory. *Neuron* 98:935–944.e935.

Rusakov DA, Bard L, Stewart MG, Henneberger C (2014) Diversity of astroglial functions alludes to subcellular specialisation. *Trends Neurosci* 37:228–242.

Sadick JS, Liddelow SA (2019) Don't forget astrocytes when targeting Alzheimer's disease. *Br J Pharmacol* 176:3585–3598.

Santello M, Toni N, Volterra A (2019) Astrocyte function from information processing to cognition and cognitive impairment. *Nat Neurosci* 22:154–166.

Schummers J, Yu H, Sur M (2008) Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. *Science* 320:1638–1643.

Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, Carrasco MA, Phatnani HP, Shum C, Wilmut I, Maniatis T, Shaw CE, Finkbeiner S, Chandran S (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. *Proc Natl Acad Sci USA* 110:4697–4702.

Sheffield ME, Dombeck DA (2015) Calcium transient prevalence across the dendritic arbour predicts place field properties. *Nature* 517:200–204.

Sheffield ME, Dombeck DA (2019) Dendritic mechanisms of hippocampal place field formation. *Curr Opin Neurobiol* 54:1–11.

Sheffield ME, Adoff MD, Dombeck DA (2017) Increased prevalence of calcium transients across the dendritic arbor during place field formation. *Neuron* 96:490–504.e495.

Shelkar GP, Gandhi PJ, Liu J, Dravid SM (2022) Cocaine preference and neuroadaptations are maintained by astrocytic NMDA receptors in the nucleus accumbens. *Sci Adv* 8:eab06574.

Shigetomi E, Bowser DN, Sofroniew MV, Khakh BS (2008) Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. *J Neurosci* 28:6659–6663.

Singh SK, Stogsdill JA, Pulimood NS, Dingsdale H, Kim YH, Pilaz LJ, Kim IH, Manhaes AC, Rodrigues WS Jr, Pamukcu A, Enustun E, Ertuz Z, Scheiffele P, Soderling SH, Silver DL, Ji RR, Medina AE, Eroglu C (2016) Astrocytes assemble thalamocortical synapses by bridging NRX1alpha and NL1 via hevin. *Cell* 164:183–196.

Siracusa R, Fusco R, Cuzzocrea S (2019) Astrocytes: role and functions in brain pathologies. *Front Pharmacol* 10:1114.

Soreq L, Rose J, Soreq E, Hardy J, Trabzuni D, Cookson MR, Smith C, Ryten M, Patani R, Ule J, UK Brain Consortium; North American Brain Expression Consortium (2017) Major shifts in glial regional identity are a transcriptional hallmark of human brain aging. *Cell Rep* 18:557–570.

Soto JS, Jami-Alahmadi Y, Chacon J, Moye SL, Diaz-Castro B, Wohlschlegel JA, Khakh BS (2023) Astrocyte-neuron subproteomes and obsessive-compulsive disorder mechanisms. *Nature* 616:764–773.

Soung A, Klein RS (2018) Viral encephalitis and neurologic diseases: focus on astrocytes. *Trends Mol Med* 24:950–962.

Stuart GJ, Spruston N (2015) Dendritic integration: 60 years of progress. *Nat Neurosci* 18:1713–1721.

Sun S, Sun Y, Ling SC, Ferraiuolo L, McAlonis-Downes M, Zou Y, Drenner K, Wang Y, Ditsworth D, Tokunaga S, Kopelevich A, Kaspar BK, Lagier-Tourenne C, Cleveland DW (2015) Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. *Proc Natl Acad Sci USA* 112:E6993–E7002.

Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y, Nedergaard M (2013) Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. *Science* 339:197–200.

Takao M, Ohira M (2023) Neurological post-acute sequelae of SARS-CoV-2 infection. *Psychiatry Clin Neurosci* 77:72–83.

Takeuchi R, Toyoshima Y, Tada M, Tanaka H, Shimizu H, Shiga A, Miura T, Aoki K, Aikawa A, Ishizawa S, Ikeuchi T, Nishizawa M, Kakita A, Takahashi H (2016) Globular glial mixed four repeat tau and TDP-43 proteinopathy with motor neuron disease and frontotemporal dementia. *Brain Pathol* 26:82–94.

Tang Y, et al. (2020) Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. *Nat Neurosci* 23:1125–1137.

Tannahill GM, et al. (2013) Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. *Nature* 496:238–242.

Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV, Khakh BS (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. *Nat Neurosci* 17:694–703.

Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, Saito Y, Arai T, Nishiyama K, Murayama S (2015) Incidence and extent of TDP-43 accumulation in aging human brain. *Acta Neuropathol Commun* 3:35.

Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. *J Neuropathol Exp Neurol* 67:555–564.

Verkhatsky A, Nedergaard M (2018) Physiology of astroglia. *Physiol Rev* 98:239–389.

Wahis J, et al. (2021) Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents. *Nat Neurosci* 24:529–541.

Wang F, Wang W, Gu S, Qi D, Smith NA, Peng W, Dong W, Yuan J, Zhao B, Mao Y, Cao P, Lu QR, Shapiro LA, Yi SS, Wu E, Huang JH (2023) Distinct astrocytic modulatory roles in sensory transmission during sleep, wakefulness, and arousal states in freely moving mice. *Nat Commun* 14:2186.

Wang J, Li KL, Shukla A, Beroun A, Ishikawa M, Huang X, Wang Y, Wang YQ, Yang Y, Bastola ND, Huang HH, Kramer LE, Chao T, Huang YH, Sesack SR, Nestler EJ, Schluter OM, Dong Y (2021) Cocaine triggers astrocyte-mediated synaptogenesis. *Biol Psychiatry* 89:386–397.

Weskamp K, Tank EM, Miguez R, McBride JP, Gomez NB, White M, Lin Z, Gonzalez CM, Serio A, Sreedharan J, Barmada SJ (2020) Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. *J Clin Invest* 130:1139–1155.

Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. *Science* 296:678–682.

Windrem MS, Osipovitch M, Liu Z, Bates J, Chandler-Militello D, Zou L, Munir J, Schanz S, McCoy K, Miller RH, Wang S, Nedergaard M, Findling RL, Tesar PJ, Goldman SA (2017) Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. *Cell Stem Cell* 21:195–208.e196.

Yu X, Taylor AM, Nagai J, Golshani P, Evans CJ, Coppola G, Khakh BS (2018) Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. *Neuron* 99:1170–1187.e1179.

Yu X, Nagai J, Marti-Solano M, Soto JS, Coppola G, Babu MM, Khakh BS (2020) Context-specific striatal astrocyte molecular responses are phenotypically exploitable. *Neuron* 108:1146–1162.e1110.

Yu X, Moye SL, Khakh BS (2021) Local and CNS-wide astrocyte intracellular calcium signaling attenuation in vivo with CalEx(flox) mice. *J Neurosci* 41:4556–4574.

Zhang B, Qiu L, Xiao W, Ni H, Chen L, Wang F, Mai W, Wu J, Bao A, Hu H, Gong H, Duan S, Li A, Gao Z (2021) Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain. *Neuron* 109:331–346.e337.
Perea G, Araque A (2005) Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. *J Neurosci* 25:2192–2203.

Perea G, Araque A (2007) Astrocytes potentiate transmitter release at single hippocampal synapses. *Science* 317:1083–1086.

Rasmussen RN, Asiminas A, Carlsen EM, Kjaerby C, Smith NA (2023) Astrocytes: integrators of arousal state and sensory context. *Trends Neurosci* 46:418–425.

Reitman ME, Tse V, Mi X, Willoughby DD, Peinado A, Aivazidis A, Myagmar BE, Simpson PC, Bayraktar OA, Yu G, Poskanzer KE (2023) Norepinephrine links astrocytic activity to regulation of cortical state. *Nat Neurosci* 26:579–593.

Remy S, Spruston N (2007) Dendritic spikes induce single-burst long-term potentiation. *Proc Natl Acad Sci USA* 104:17192–17197.

Ribot J, Breton R, Calvo CF, Moulard J, Ezan P, Zapata J, Samama K, Moreau M, Bemelmans AP, Sabatet V, Dingli F, Loew D, Milleret C, Billuart P, Dallerac G, Rouach N (2021) Astrocytes close the mouse critical period for visual plasticity. *Science* 373:77–81.

Robin LM, et al. (2018) Astroglial CB₁ receptors determine synaptic D-serine availability to enable recognition memory. *Neuron* 98:935–944.e935.

Rusakov DA, Bard L, Stewart MG, Henneberger C (2014) Diversity of astroglial functions alludes to subcellular specialisation. *Trends Neurosci* 37:228–242.

Sadick JS, Liddelow SA (2019) Don't forget astrocytes when targeting Alzheimer's disease. *Br J Pharmacol* 176:3585–3598.

Santello M, Toni N, Volterra A (2019) Astrocyte function from information processing to cognition and cognitive impairment. *Nat Neurosci* 22:154–166.

Schummers J, Yu H, Sur M (2008) Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. *Science* 320:1638–1643.

Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, Carrasco MA, Phatnani HP, Shum C, Wilmut I, Maniatis T, Shaw CE, Finkbeiner S, Chandran S (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. *Proc Natl Acad Sci USA* 110:4697–4702.

Sheffield ME, Dombeck DA (2015) Calcium transient prevalence across the dendritic arbour predicts place field properties. *Nature* 517:200–204.

Sheffield ME, Dombeck DA (2019) Dendritic mechanisms of hippocampal place field formation. *Curr Opin Neurobiol* 54:1–11.

Sheffield ME, Adoff MD, Dombeck DA (2017) Increased prevalence of calcium transients across the dendritic arbor during place field formation. *Neuron* 96:490–504.e495.

Shelkar GP, Gandhi PJ, Liu J, Dravid SM (2022) Cocaine preference and neuroadaptations are maintained by astrocytic NMDA receptors in the nucleus accumbens. *Sci Adv* 8:eab06574.

Shigetomi E, Bowser DN, Sofroniew MV, Khakh BS (2008) Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. *J Neurosci* 28:6659–6663.

Singh SK, Stogsdill JA, Pulimood NS, Dingsdale H, Kim YH, Pilaz LJ, Kim IH, Manhaes AC, Rodrigues WS Jr, Pamukcu A, Enustun E, Ertuz Z, Scheiffele P, Soderling SH, Silver DL, Ji RR, Medina AE, Eroglu C (2016) Astrocytes assemble thalamocortical synapses by bridging NRX1alpha and NL1 via hevin. *Cell* 164:183–196.

Siracusa R, Fusco R, Cuzzocrea S (2019) Astrocytes: role and functions in brain pathologies. *Front Pharmacol* 10:1114.

Soreq L, Rose J, Soreq E, Hardy J, Trabzuni D, Cookson MR, Smith C, Ryten M, Patani R, Ule J, UK Brain Consortium; North American Brain Expression Consortium (2017) Major shifts in glial regional identity are a transcriptional hallmark of human brain aging. *Cell Rep* 18:557–570.

Soto JS, Jami-Alahmadi Y, Chacon J, Moye SL, Diaz-Castro B, Wohlschlegel JA, Khakh BS (2023) Astrocyte-neuron subproteomes and obsessive-compulsive disorder mechanisms. *Nature* 616:764–773.

Soung A, Klein RS (2018) Viral encephalitis and neurologic diseases: focus on astrocytes. *Trends Mol Med* 24:950–962.

Stuart GJ, Spruston N (2015) Dendritic integration: 60 years of progress. *Nat Neurosci* 18:1713–1721.

Sun S, Sun Y, Ling SC, Ferraiuolo L, McAlonis-Downes M, Zou Y, Drenner K, Wang Y, Ditsworth D, Tokunaga S, Kopelevich A, Kaspar BK, Lagier-Tourenne C, Cleveland DW (2015) Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. *Proc Natl Acad Sci USA* 112:E6993–E7002.

Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y, Nedergaard M (2013) Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. *Science* 339:197–200.

Takao M, Ohira M (2023) Neurological post-acute sequelae of SARS-CoV-2 infection. *Psychiatry Clin Neurosci* 77:72–83.

Takeuchi R, Toyoshima Y, Tada M, Tanaka H, Shimizu H, Shiga A, Miura T, Aoki K, Aikawa A, Ishizawa S, Ikeuchi T, Nishizawa M, Kakita A, Takahashi H (2016) Globular glial mixed four repeat tau and TDP-43 proteinopathy with motor neuron disease and frontotemporal dementia. *Brain Pathol* 26:82–94.

Tang Y, et al. (2020) Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. *Nat Neurosci* 23:1125–1137.

Tannahill GM, et al. (2013) Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. *Nature* 496:238–242.

Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV, Khakh BS (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. *Nat Neurosci* 17:694–703.

Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, Saito Y, Arai T, Nishiyama K, Murayama S (2015) Incidence and extent of TDP-43 accumulation in aging human brain. *Acta Neuropathol Commun* 3:35.

Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. *J Neuropathol Exp Neurol* 67:555–564.

Verkhatsky A, Nedergaard M (2018) Physiology of astroglia. *Physiol Rev* 98:239–389.

Wahis J, et al. (2021) Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents. *Nat Neurosci* 24:529–541.

Wang F, Wang W, Gu S, Qi D, Smith NA, Peng W, Dong W, Yuan J, Zhao B, Mao Y, Cao P, Lu QR, Shapiro LA, Yi SS, Wu E, Huang JH (2023) Distinct astrocytic modulatory roles in sensory transmission during sleep, wakefulness, and arousal states in freely moving mice. *Nat Commun* 14:2186.

Wang J, Li KL, Shukla A, Beroun A, Ishikawa M, Huang X, Wang Y, Wang YQ, Yang Y, Bastola ND, Huang HH, Kramer LE, Chao T, Huang YH, Sesack SR, Nestler EJ, Schluter OM, Dong Y (2021) Cocaine triggers astrocyte-mediated synaptogenesis. *Biol Psychiatry* 89:386–397.

Weskamp K, Tank EM, Miguez R, McBride JP, Gomez NB, White M, Lin Z, Gonzalez CM, Serio A, Sreedharan J, Barmada SJ (2020) Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. *J Clin Invest* 130:1139–1155.

Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. *Science* 296:678–682.

Windrem MS, Osipovitch M, Liu Z, Bates J, Chandler-Militello D, Zou L, Munir J, Schanz S, McCoy K, Miller RH, Wang S, Nedergaard M, Findling RL, Tesar PJ, Goldman SA (2017) Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. *Cell Stem Cell* 21:195–208.e196.

Yu X, Taylor AM, Nagai J, Golshani P, Evans CJ, Coppola G, Khakh BS (2018) Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. *Neuron* 99:1170–1187.e1179.

Yu X, Nagai J, Marti-Solano M, Soto JS, Coppola G, Babu MM, Khakh BS (2020) Context-specific striatal astrocyte molecular responses are phenotypically exploitable. *Neuron* 108:1146–1162.e1110.

Yu X, Moye SL, Khakh BS (2021) Local and CNS-wide astrocyte intracellular calcium signaling attenuation in vivo with CalEx(flox) mice. *J Neurosci* 41:4556–4574.

Zhang B, Qiu L, Xiao W, Ni H, Chen L, Wang F, Mai W, Wu J, Bao A, Hu H, Gong H, Duan S, Li A, Gao Z (2021) Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain. *Neuron* 109:331–346.e337.